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Musculoskeletal disorders in humans present with a broad range of phenotypes that vary
in severity, onset, and genetic cause. The musculoskeletal system is comprised of complex and
diverse tissues that make up the majority of total body mass. Thus, mutations in many different
genes with differing structure and function can produce phenotypically similar developmental and
morphological defects in the muscle and skeleton. In addition, the muscular and skeletal systems
develop non-autonomously, wherein development and function of each will affect development of
the other. Thus, mutations in genes responsible for development of this complex system have the
potential to influence morphogenesis outside of their tissue of expression. Many different gene
defects have the potential to cause musculoskeletal disorders and to properly treat afflicted patients
it is necessary to understand the underlying causes of pathogenesis.
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One such example of pathogenic morphogenesis is Distal Arthrogryposis (DA), a group of
ten congenital disorders characterized by contractures of the joints of the distal limbs that presents
at birth. The most severe form of DA, Freeman-Sheldon syndrome (DA2A), is most commonly
associated with autosomal dominant missense mutations in the motor domain of MYH3, a
sarcomeric embryonic myosin heavy chain gene expressed in developing skeletal muscle. While
this gene is expressed only transiently in skeletal muscle tissue, symptoms present in the structure
of skeletal joints and persist beyond birth.
To examine the disease mechanism responsible for developing skeletal muscle and joint
contracture and to explore treatment options for afflicted patients, we created the most commonly
observed human DA2A pathogenic variant (MYH3R672H) in the analogous gene in zebrafish
(smyhc1R673H). The heterozygous zebrafish had contractures of the spine that modeled the
phenotype of DA2A patient’s muscle contractures. We observed shortened muscle fibers and
sarcomeres, disorganized skeletal muscle tissue, and disrupted motor activity. The phenotype was
rescued with an actin-myosin inhibitor, para-aminoblebbistatin, suggesting that contractures are
caused by constitutive muscle contraction.
While we were able to characterize the phenotype of this pathogenic variant, many variants
of unknown significance have been recorded in the motor domain of MYH3. Given the labor and
time required to generate missense mutants using traditional methods, a higher throughput means
of mutant generation is necessary to examine the function of dozens of reported variants. To
develop a higher throughput method of analyzing single variants, we created zebrafish lines that
would be expected to enable high-throughput screening. A GFP reporter tag at the end of smyhc1
is used as a marker for successful homology directed repair. A deletion is induced where reported
variants cluster in the human analog that also serves to put GFP out of frame. In-frame repair and

xv

integration of a variant of interest via a repair template returns GFP into frame, allowing for
efficient screening of F0 embryos.
Finally, we analyzed a fibronectin domain containing 1 (fndc1) zebrafish knockout to
better understand its association with human scoliosis. fndc1 zebrafish mutants displayed a higher
bone mineral density and slightly larger vertebral centra, though scoliosis was not present. Using
zebrafish to model musculoskeletal disease, we were able to elucidate disease mechanisms of distal
arthrogryposis and scoliosis, as well as develop more efficient methods for variant analysis in
zebrafish.

xvi

Chapter 1: Introduction and Perspective
1.1 Preface
Parts of this chapter were adapted from the following manuscript:
Whittle, Julia, Aaron Johnson, Matthew B. Dobbs, and Christina A. Gurnett. "Models of distal
arthrogryposis and lethal congenital contracture syndrome." Genes 12, no. 6 (2021): 943.
Author Contributions:
J.W. and C.A.G. wrote the first draft of the manuscript. J.W., A.J., M.B.D. and C.A.G. wrote or
critically reviewed the manuscript, and reviewed and approved the final version. All authors have
read and agreed to the published version of the manuscript.
1.2 Arthrogryposis
Arthrogryposis (arth = joint; grp = curved; osis = pathological state) describes a broad
range of disorders consisting of multiple congenital joint contractures presenting at birth (Hall,
2014). About 1 in 3000 live births presents with some form of arthrogryposis, many of which are
nonprogressive and improve with physiotherapy (Hall, 1997; Hall, 2014; Ravenscroft et al, 2020).
The core cause of arthrogryposis is fetal akinesia, or lack of fetal movement, that results in
contractures forming in the joints (Hall, 1997; Hall, 2014; Ravenscroft et al, 2020). Movement is
required for normal joint development; it influences the structure of the joints and promotes
cellular signaling to guide normal tissue development. Mechanical forces also influence bone
morphology, which affects the organization of chondrocytes, bone elongation, and differential
growth, to impact the shape of bones as they develop. Fetal akinesia impairs joint formation by
inhibiting both normal development of joints and bones, which may lead to joint and bony fusions.
Furthermore, tension is required for normal tendon development, which forms a connection
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between bone and muscle (Felsenthal & Zelzer, 2017). Arrested movement during development
has significant impact on the formation of the skeleton, joints, muscle, and connective tissues.
Akinesia can be caused by both genetic and environmental factors. Over 400 genes are
associated with arthrogryposis broadly, encapsulating a wide diversity of genes affecting different
pathways, including axon structure, circulatory development, or synaptic transmission (Kiefer &
Hall, 2019). Extrinsically, maternal disease or exposures, uterine space limitation, and decreased
blood supply are also root causes for contraction defects that may lead to arthrogryposis (Hall,
1997; Hall, 2014).
1.2.1 Distal Arthrogryposis
A subset of arthrogryposis is described as Distal Arthrogryposis (DA), a group of
congenital contractures that predominantly affect the joints of the distal limbs, including the hands,
wrists, ankles, and feet. Clinically, the lower extremity manifestations commonly include clubfoot
and vertical talus. There are currently 10 classifications of DA, including Sheldon-Hall syndrome
(DA2B) and Freeman-Sheldon syndrome (DA2A) (Bamshad et al, 2009; Beck et al, 2014; Scala
et al, 2018; Toydemir et al, 2006). Freeman-Sheldon syndrome is considered the most severe form
of DA, also presenting with facial contractures (Toydemir et al, 2006). This range of disorders can
negatively impair patient quality of life through muscle weakness, generalized pain, and
diminished motor function (Kimber et al, 2012).
1.2.2 Current treatment methods
Currently, DA patients are offered supportive care to improve quality of life, including
occupational therapy, physical therapy, and surgery (Desai et al, 2020). While these treatments
improve outcome for patients, they often fall short of complete restoration of range of motion in
the joints and functionality. This strategy also fails to address underlying causes for DA, such as
2

muscle weakness and impaired neurotransmission. Therefore, further investigation is necessary to
understand the impact of disease variants which will allow us to determine the most effective
treatment options for patients.
1.2.3 Genetics of Distal Arthrogryposis
While over 400 genes are associated with arthrogryposis, including a wide diversity of
genes affecting different pathways, mutations associated with DA are observed at a high rate in
skeletal muscle and neural genes (Bamshad et al, 2009; Desai et al, 2020). Specifically, the most
common genetic causes of severe DA are autosomal dominant missense mutations in MYH3, a
myosin heavy chain (MyHC) gene expressed early in human development (Alvarado et al, 2011;
Beck et al, 2013; Beck et al, 2014; Scala et al, 2018; Tajsharghi et al, 2008; Toydemir et al, 2006;
Zhao et al, 2022).
1.3 Embryonic Myosin Heavy Chain
MyHCs are large, dimerizing, ATP-dependent motor proteins that bundle together in thick
filaments to drive muscle contraction. They consist of a large ATPase domain and long tail domain
linked by a coiled coil. These proteins dimerize and bundle together in thick filaments that drive
muscle contraction by binding to actin in the sarcomere (Carraro & Catani, 1983; Schiaffino et al,
2015; Zhao et al, 2022) (Figure 1.1). MyHCs are critical for both structural organization of the
sarcomere and driving contraction.
It is common for embryonic isoforms of proteins to be expressed transiently in
development before adult isoforms populate the tissue (Schiaffino et al, 2015; Tajsharghi et al,
2008; Zhao et al, 2022). Developmental MyHC genes are conserved in vertebrates, with these
isoforms identified in birds and fish as well as mice and humans. In developing skeletal muscle,
embryonic and neonatal forms of MyHCs are expressed. They are downregulated significantly as
3

adult MyHCs begin expression (Schiaffino et al, 2015; Smerdu, 2002). However, there is evidence
that some adult muscle tissues continue to express developmental forms of MyHC in adulthood.
Muscle such as the extraocular muscle and jaw-closing muscles appear to continue to express
embryonic MyHC in adulthood. Typically, these genes are co-expressed with other MyHC
isoforms (Schiaffino et al, 2015; Wieczorek et al, 1985). There is also evidence that these genes
resume expression during muscle regeneration (Schiaffino et al, 2015; Tajsharghi et al, 2008; Zhao
et al, 2022).
The evolutionary advantage of distinct developmental MyHC proteins is not well known. It is
possible that these proteins have structural properties that allow them to organize the sarcomere
more effectively. There is also functional evidence that these proteins consume ATPase at a lower
rate than adult isoforms (Sieck et al, 2003). This suggests that embryonic MyHCs may have a
lower contractile capacity (Schiaffino et al, 2015). Indeed, human muscle fibers containing
embryonic MyHC isoforms have been found to generate less than 1/10th the force of adult muscle
fibers (Racca et al, 2013). While the physical properties of these proteins have been studied, the
evolutionary advantage of dedicated embryonic MyHC isoforms is not well known. It is possible
that the lower force production is well-suited to delicate embryonic tissue. This may explain why
these proteins have been observed to be expressed in delicate muscles such as the extraocular
muscle as well (Wieczorek et al, 1985).
1.3.1 MYH3
MYH3 is the earliest expressed embryonic MyHC gene in humans where it is
predominantly expressed in myotubes destined to become fast-twitch myofibers (Toydemir et al,
2006). MYH3 expression peaks during fetal development, and is significantly downregulated
before birth (Karsch-Mizrachi et al, 1989; Smerdu, 2002). Missense mutations in MYH3 are
4

strongly associated with DA clinically, and contribute to multiple subtypes including DA1, DA2A,
and DA2B which have varying degrees of severity (Alvarado et al, 2011; Beck et al, 2013; Beck
et al, 2014; Scala et al, 2018; Toydemir et al, 2006; Zhao et al, 2022). Notably, phenotypes caused
by these mutations persist into adulthood without surgical intervention, long after MYH3
expression has ceased expression.
1.3.2 smyhc1
slow myosin heavy chain 1 (smyhc1) is an embryonic isoform of MyHC expressed in
developing zebrafish slow muscle. In situ data has detected smyhc1 expression as early as 12 hours
post fertilization (hpf) in the somites (Rauch et al, 2003). Specifically, the adaxial cells of the
somites, adjacent to the notochord, express smyhc1. These cells migrate away from the notochord
toward the lateral sides of the trunk, and differentiate into slow muscle tissue (Devoto et al, 1996).
1.4 Embryonic MyHC models for DA
The most common genetic causes of DA are autosomal dominant missense mutations in
MYH3 (Scala et al, 2018; Schiaffino et al, 2015; Toydemir et al, 2006; Zhao et al, 2022). MYH3
mutations have been identified in multiple DA syndromes, including distal arthrogryposis, type 1
(DA1), DA2A, and distal arthrogryposis type 2B (DA2B) (also called Sheldon-Hall syndrome)
(Alvarado et al, 2011; Beck et al, 2013; Toydemir et al, 2006). MYH3 mutations have additionally
been identified in patients with multiple pterygium syndrome, and spondylocarpotarsal synostosis
syndrome, which is associated with vertebral, carpal, and tarsal fusions in addition to joint
contractures (Cameron-Christie et al, 2018; Carapito et al, 2016; Chong et al, 2015; Zieba et al,
2017).
Various disease models have been developed to examine the mechanisms behind DA
pathogenesis and to test therapeutic interventions. Molecular and single-cell studies are useful for
5

precisely examining the effects of DA-causing variants on the affected proteins and tissues (Racca
et al, 2015; Walklate et al, 2016). Access to human tissues, particularly from muscle biopsies, has
facilitated molecular analysis for research, yet is clinically useful only in select cases as patient
variability is so high (Kimber et al, 2012). Protein modeling can help predict the impact of various
amino acid substitutions on molecular interactions and protein activity (Del Angel et al, 2020; Yip
et al, 2004). However, animal models are necessary to analyze the effect of single gene variants
on organisms on scales larger than single cells. The interaction between cells and tissues in animal
models allows us to study non-cell autonomous effects of genes and genetic variants. The effect
of zygosity and gene dosage may also be better studied in animal models to assess interactions
between normal and abnormal gene products. Animal models are also useful for studying
experimental interventions that may improve patient quality of life and outcome, acting as standins for potential human patients.
Models of human disease are rapidly becoming more sophisticated with the ability to
knock-in single nucleotide variants and create conditional (tissue specific or time-dependent)
knockouts (Ablain et al, 2015; Zhang et al, 2012a; Zhuo et al, 2021). Loss-of-function alleles,
which are often easier to generate, provide critical information about gene function, but may not
fully explain autosomal dominant phenotypes, in which gain-of-function or dominant negative
alleles can cause markedly different phenotypes. Therefore, in many cases loss-of-function alleles
do not act as analogs for pathogenic alleles. Conditional knockouts, while very helpful in defining
gene function, rarely replicate the human phenotype in its entirety, but may be required when early
lethality limits further study. These methods allow researchers to design models that more
accurately represent these human conditions and replicate pathogenic effects broadly or in specific
tissues.

6

1.4.1 Single cell and single molecule studies
Single molecule and single cell studies are useful to examine the precise impact of a variant
on protein function. The effects of amino acid substitutions are difficult to predict without
mechanistic examination. These substitutions can affect protein folding, ligand interaction, protein
stability, and more (Stefl et al, 2013; Yip et al, 2004; Zhang et al, 2012b). Single-molecule studies
facilitate understanding the effect of a missense variant on protein function and can later be
translated into an understanding of how small mechanical differences affect tissues and whole
body systems (Walklate et al, 2016). Missense variants can be directly studied in human skeletal
muscle biopsies as well (Kimber et al, 2012). However, these are not routinely performed for DA
diagnosis, which makes these studies challenging. To study the mechanistic link between DA
phenotype and gene variant, Racca et al. performed contractility studies on isolated muscle cells
and myofibrils derived from biopsied muscle tissue from DA2A patients. They found that a DA2Aassociated MYH3 variant inhibited cross-bridge detachment, thereby slowing muscle relaxation
and lowering force production (Racca et al, 2015). A later study replicated these results while
examining multiple MYH3 variants associated with DA2. In addition to slower actin-myosin
detachment, ATP binding and ATPase activity were lower in variant MYH3 molecules (Walklate
et al, 2016).
Development of single cell models, in which MYH3 variants are exogenously expressed or
overexpressed from a plasmid or virus, have been limited by the difficulties of expressing large
genes, like MYH3, in vitro. For similar reasons, RNA-induced expression induction in
multicellular organisms is also limited. Likewise, because many features of DA are due to complex
relationships between different cell types, co-cultures of muscle cells with tenocytes and bone may
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be required to recapitulate the human condition. Thus, many investigators have preferred to study
DA genes in whole organisms.
1.4.2 Drosophila models
Drosophila melanogaster (fruit flies) are useful tools for studying muscle function and
myofibril assembly, particularly as introduction of single variants are traditionally simpler in this
system compared to other models. MYH3 and the Drosophila myosin heavy chain gene, Mhc, are
highly conserved. Drosophila have the advantage of having only a single myosin heavy chain,
which eliminates the possible obfuscation of effects due to compensation by other myosin heavy
chain analogs. Therefore, the effect of variants on protein function can be examined in a setting
without other myosin heavy chain isoforms.
Drosophila transgenic models have been generated by overexpressing Mhc constructs
containing DA variants (Das et al, 2019). Guo et al. predicted that a DA1 variant would perturb a
hydrophobic interaction, while a DA2B mutation would introduce a hydrogen bond that was not
present in the wild type (Guo et al, 2020). The effect of these predicted interactions was tested
mechanistically in Drosophila models. Muscle fibers containing the DA alleles were extracted and
found to have lower actin affinity, reduced power output, and increased stiffness, which may
explain the motor deficits (Guo et al, 2020).
Morphological studies of Drosophila skeletal muscle expressing three DA2A Mhc
transgenes (R672H, R672C, and T178I) showed branching and splitting defects, which were most
severe in the R672C variant, which caused Z-discs to be split and malformed. In addition, Z-disc
distance was shorter in the transgenic flies indicating an overall shortening of the sarcomeres,
perhaps due to an enhanced contractile state of the myofibers. Presumably, the shortened
sarcomeres observed in Drosophila contribute to the formation of contractures in human patients.
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Indeed, ATPase activity was reduced in these transgenic flies, leading to functional defects in
muscle activity (Das et al, 2019).
In studying the intact adult Drosophila, Guo et al. showed that the MhcF437I mutants had
a much longer lifespan than MhcA234T mutants, consistent with the less severe phenotype of DA1
patients compared to DA2B patients (Guo et al, 2020). In addition, the researchers found that both
mutants displayed aberrant myofibril assembly, as well as misaligned sarcomere structure
including distorted M and Z lines. Again, this phenotype was more severe in A234T mutants than
in the F437I mutants. MhcF437I mutants displayed essentially normal myofibers and sarcomeres,
while MhcA234T mutants had small myofibers with disrupted morphology, as well as abnormal
sarcomeres (Guo et al, 2020). Das et al. also found that decreased climbing capability of adult flies
also correlated with the phenotypic severity in humans (Das et al, 2019).
1.4.3 C. elegans models
Like Drosophila, Caenorhabditis elegans (C. elegans) has also been used to study myosin
heavy chain genes (Gil-Gálvez et al, 2020). There are many advantages of C. elegans and
Drosophila for disease modeling, including large numbers of progeny, knowledge of ontogeny of
individual cells, and ease of functional studies for drug screening. However, as described in GilGalvez et al., the evolutionary distance, and differences in number of myosin heavy chain genes
between invertebrates and humans makes it difficult to determine whether the gene being studied
has the same function, particularly in terms of spatial and temporal expression, as its human
counterpart. Furthermore, Gil-Galvarez et al. caution against overexpression studies in C. elegans
broadly, citing interference with muscle cell function overall (Gil-Gálvez et al, 2020). The major
drawback of invertebrate models is, quite obviously, the lack of skeletal structures which limits
their use in understanding the complex relationship between muscle, nerve, and bone.
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1.4.4 Limitations of current models
The musculoskeletal system is complex, with an entwined relationship between bone,
muscle, nerve, and joints. Because the previously described models are invertebrate or in vitro,
this system cannot be holistically examined analogously to human patients. While these models
are helpful in analyzing kinetic properties and molecular effects of these mutations, it is difficult
to examine the functional disease mechanism by which MyHC mutations lead to skeletal and joint
deformities. Therefore, there is a need for vertebrate models for DA to more accurately depict the
disorder and assess treatment options.
1.5 Scoliosis
Scoliosis is defined as a lateral curvature of the spine. Severity is calculated by the Cobb
angle. Typically, a deviation of 10 degrees or greater is defined as scoliosis (Carman et al, 1990;
Cobb, 1948) (Figure 1.2). In severe cases, patients may be treated with surgery or a back brace to
correct the curvature. Scoliosis can be congenital and comorbid with other musculoskeletal
conditions (Janicki & Alman, 2007). However, it commonly arises in patients with no apparent
cause, which is known as idiopathic.
1.5.1 Adolescent Idiopathic Scoliosis
Scoliosis is the most common spinal deformity in children, characterize by a lateral spinal
curve with a Cobb angle > 10o (Konieczny et al, 2013). In more than 80% of patients, scoliosis is
idiopathic, meaning the cause in that specific patient is unclear, and uncoupled with apparent spinal
deformities such as bony fusions. It also most commonly arises during adolescence (Lonstein,
1994). Adolescent idiopathic scoliosis (AIS) is a common disorder, with a prevalence reported up
to 5.2% in current population studies (Konieczny et al, 2013). Both prevalence and severity are
more common in females than males (Lonstein, 1994; Tajsharghi et al, 2008). In severe cases,
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surgery and bracing are required. This condition typically runs in families, implying underlying
genetic causes for its onset and progression (Wynne-Davies, 1968). Although the genetic factors
that contribute to severe AIS are largely unknown, it is suspected that the disorder is a complex
trait caused by multiple genetic risk factors contributing to an additive effect on morphology.
1.5.2 Genetics of AIS
While AIS has been observed to run in families, the specific genetic factors that contribute
to onset and progression are largely unknown. It follows that the mechanistic effects of these
mutations that lead to scoliosis are unclear. While some common genetic loci such as LBX1
(ladybird homeobox 1), GPR126 (G-protein coupled receptor 126)7, BNC2 (basonuclin 2), PAX1
(paired box 1), and SLC39A8 (Solute Carrier Family 39 Member 8) have been associated with
AIS, reported loci account for less than 5% of AIS heritability (Haller et al, 2018; Kou et al, 2019;
Kou et al, 2013; Ogura et al, 2015; Sharma et al, 2015; Takahashi et al, 2011). To further
complicate AIS genomic study, these genes encode a wide variety of protein function, from cell
migration regulatory agents to solute transporters (Gross et al, 2000; Park et al, 2015). The
pathways attributable to AIS are therefore largely unknown, and the mechanistic basis for AIS
onset and progression are unclear.
To further complicate study, AIS is suspected to be a complex trait, where multiple
common and rare variants culminate in a deleterious effect that would not be detectable with a
single mutant. AIS is not a Mendelian disorder and the phenotype can only rarely be linked to a
specific genetic locus that segregates cleanly. Therefore, modern methods of genome analysis are
necessary to find the complex gene associations that additively culminate in AIS (Risch, 2000).
Currently, genome-wide association studies (GWAS) of common variants and rare variant
gene burden analysis are strong tools for determining genetic risk factors for AIS. GWAS studies
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aim to connect complex traits to the genetic loci associated with them. With a large enough sample
size, statistical analysis of an association of common variants to a disease phenotype can be
detected when compared to a control set. They are useful in detecting single nucleotide
polymorphisms (SNPs) in association with diseases (such as AIS) on a population-wide scale
(Cantor et al, 2010; Visscher et al, 2012). On the other hand, rare variant gene burden analyses
seeks to identify genes in which rare variants are found more commonly in a disease cohort versus
a control cohort (Guo et al, 2018).
Conducting these studies in families to find genes and variants associated with AIS gives
us a broader understanding of alleles that carry risk for AIS development, and how they may
combine to manifest in differing scoliosis severity. In addition, documentation of mutations in
different genes that contribute to AIS will allow us to develop models, test and determine the
mechanisms leading to the deformity in specific cases, and how best to approach treatment
precisely for each patient.
1.6 Dissertation objectives
Disorders such as DA and AIS are caused by a broad array of gene variants, so that it is
difficult to study without analyzing a multitude of variants and genes. Furthermore, patients’ cases
may require specialized treatment. To approach this, a precision-based approach to research will
allow us to better understand the multitude of mechanisms driving these disorders and tailor
treatment accordingly. To do this, we used both a knock-in DA zebrafish model, and a GWAS
exome analysis to identify genes associated with severe AIS.
In Chapter 2, we created and characterized a DA zebrafish model by knocking in the most
common variant associated with DA2A, (the most severe form of DA), MYH3R672H. In zebrafish,
the analogous variant is smyhc1R673H, and these mutants phenocopied the human disorder. In
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human DA patients, the MYH3 missense mutations are always heterozygous and present with
contractures of the hands and feet. In our heterozygous zebrafish, we observed notochord
contractures in early larval stages that persisted to adulthood. We also functionally assessed muscle
structure and function in these fish. This phenotype was corrected by treating the fish with paraaminoblebbistatin, a MyHC ATPase inhibitor that prevents MyHC and actin from interacting. This
suggests that this allele causes a DA phenotype by causing constitutive contraction in the
developing muscle.
In Chapter 3, we continue this investigation by developing a higher-throughput method of
examining variants of interest in a zebrafish model. By inserting a GFP tag at the end of smyhc1,
we are able to screen for successful variant integration more easily. A large region of interest
excised from the gene puts the GFP out of frame, and a successful repair with a variant of unknown
significance (VUS) will put the GFP back in frame, allowing for efficient screening of F0 embryos.
Because the tissue smyhc1 is expressed in does not fuse, future studies may be able to examine
and characterize the sarcomeric structure and muscle phenotype of GFP positive cells in mosaic
F0 zebrafish.
Finally, in Chapter 4, we perform a gene burden analysis on whole exome data in patients
affected by severe AIS compared to a control cohort. We were able to identify an enrichment of
core matrisome genes, with the most significant enrichment of variants in FNDC1 (fibronectin
domain containing 1). To gain a better understanding of the function of this gene and how it may
contribute to scoliosis development, we examined fndc1 mutant zebrafish. In these mutants, we
found an increase in bone mineral density in the vertebrae, a phenotype that also scaled with mutant
allele frequency.
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This work uses zebrafish models to better understand the musculoskeletal disorders of DA
and AIS. These conditions are currently treated symptomatically, but a greater understanding of
the underlying genetic causes will allow us to intervene to prevent disease or progression. An
understanding of the genes at play also gives us a broader perspective of their role in development.
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Figure 1.1 Diagram of dimerized myosin heavy chain and sarcomere. Myosin
heavy chain dimerizes and bundles into thick filaments that drive contraction of the
sarcomere.
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Figure 1.2 Diagram of Cobb angle calculation.
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2.1 Abstract
Distal arthrogryposis (DA) is group of syndromes characterized by congenital joint contractures.
Treatment development is hindered by the lack of vertebrate models. Here, we describe a zebrafish
model in which a common MYH3 missense mutation (R672H) was introduced into the orthologous
zebrafish gene smyhc1 (slow myosin heavy chain 1) (R673H). We simultaneously created
a smyhc1 null allele (smyhc1−), which allowed us to compare the effects of both mutant alleles on
muscle and bone development, and model the closely related disorder, spondylocarpotarsal
synostosis syndrome. Heterozygous smyhc1R673H/+ embryos developed notochord kinks that
progressed to scoliosis with vertebral fusions; motor deficits accompanied the disorganized and
shortened slow-twitch skeletal muscle myofibers. Increased dosage of the mutant allele in both
homozygous smyhc1R673H/R673H and transheterozygous smyhc1R673H/− embryos exacerbated the
notochord

and

muscle

abnormalities,

causing

early

lethality.

Treatment

of smyhc1R673H/R673H embryos with the myosin ATPase inhibitor, para-aminoblebbistatin, which
decreases actin–myosin affinity, normalized the notochord phenotype. Our zebrafish model
of MYH3-associated DA2A provides insight into pathogenic mechanisms and suggests a beneficial
therapeutic role for myosin inhibitors in treating disabling contractures.
2.2 Introduction
Distal arthrogryposis (DA) describes a group of congenital musculoskeletal syndromes
characterized by contractures in the joints of the hands and feet. Classification systems currently
describe ten closely related DA subtypes, the most severe of which is Freeman-Sheldon Syndrome
(also called distal arthrogryposis, type 2A [DA2A]). Children born with DA2A present with
characteristic contractures of the hands, clubfeet, and facial contractures. They often develop
scoliosis (Beck et al, 2013; Toydemir et al, 2006). Complications of DA, particularly DA2A,
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include difficulty eating, respiratory issues, and impaired speech and mobility. Currently,
supportive treatments including bracing, physical therapy, and surgical interventions, are the only
therapeutic options for DA patients; however these therapies are often suboptimal (Boehm et al,
2008; Stevenson et al, 2006).
The most common genetic causes of DA are autosomal dominant missense mutations in
the MYH3 gene, encoding the embryonic myosin heavy chain (MyHC) that is expressed first
during slow skeletal muscle development. MYH3 expression peaks during fetal development, and
is significantly downregulated after birth (Cameron-Christie et al, 2018; Chong et al, 2015;
Schiaffino et al, 2015). MYH3 mutations have been identified in multiple DA syndromes, including
distal arthrogryposis, type 1 (Alvarado et al, 2011), DA2A, and distal arthrogryposis, type 2B
(DA2B)(also called Sheldon-Hall syndrome) (Beck et al, 2013; Toydemir et al, 2006). MYH3
mutations have additionally been identified in patients with multiple pterygium syndrome (Chong
et al, 2015), and spondylocarpotarsal synostosis syndrome, which is associated with vertebral,
carpal and tarsal fusions in addition to joint contractures (Cameron-Christie et al, 2018; Carapito
et al, 2016; Zieba et al, 2017).
MyHCs are large, dimerizing, ATP dependent motor proteins that bundle together in thick
filaments to drive muscle contraction. The most common DA-causing MYH3 mutations cluster in
the ATPase region of the MyHC motor domain (Fitts, 2008; Toydemir et al, 2006). The dominant
inheritance pattern of DA mutations implies a hypermorphic, neomorphic, or antimorphic nature.
The functional effects of DA-associated MYH3 missense mutations include slowing the muscle
relaxation time and prolonging the muscle fiber contracted state (Racca et al, 2015; Walklate et al,
2016). While the vast majority of described DA mutations are dominant missense variants, the
recent identification of autosomal recessive MYH3 variants in spondylocarpotarsal synostosis
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syndrome suggests that some mutations may also contribute to disease pathogenesis through a loss
of function, or hypomorphic mechanism (Cameron-Christie et al, 2018).
Understanding the mechanism by which dominant or recessive MYH3 mutations cause
contractures or bony fusions has been limited by poor access to human tissue, particularly during
early development when the gene is most highly expressed. Analysis of muscle biopsies from
adults with the MYH3 R672C mutation, which is the most common recurrent variant causing
DA2A and DA2B (Toydemir et al, 2006), revealed increased relaxation time and impaired
sarcomeric cycling (Racca et al, 2015). Recombinantly expressed MYH3 R672C, R672H, and
T178I mutations in cultured cells also caused marked abnormalities in molecular kinetic properties
including slower cycling time (Walklate et al, 2016). While the molecular effects of pathogenic
MYH3 mutations have been modeled in Drosophila (Rao et al, 2019), mutations have yet to be
studied in vertebrate models where their impact on muscle and skeletal development can be
concurrently assessed.
To address the need for vertebrate models of DA, we created a zebrafish line in which the
most common human DA2A MYH3 mutation, R672H, was precisely edited into the corresponding
amino acid of the slow myosin heavy chain 1 gene (smyhc1R673H [stl583]) (Roy et al, 2001). This
gene is expressed in the somites as early as 5–9 somite stages, and in the lateral slow muscle of
the trunk, as evidenced by previously conducted in situ hybridization (Bessarab et al, 2008; Li et
al, 2020; Rauch et al, 2003). We simultaneously created a smyhc1 null allele (smyhc1- [stl582]),
which allowed us to compare the effects of both mutant alleles on slow skeletal muscle and bone
development.
Remarkably, the smyhc1- allele in the homozygous state caused transient muscle
abnormalities in larvae and late onset scoliosis, whereas the smyhc1R673H allele resulted in
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notochord kinks, abnormally shortened muscle, and vertebral fusions with the severity of the
phenotype correlating with allele dosage. The early notochord phenotype was suppressed or
normalized with para-aminoblebbistatin, a drug that reduces myosin-actin affinity by inhibiting
myosin ATPase activity, which directly inhibits muscle contraction (Várkuti et al, 2016). Because
removing muscle contraction suppressed the abnormal notochord phenotype, we interpret this
result as supporting our hypothesis that the smyhc1R673H allele causes hypermorphic muscle
contraction that creates excessive tension on the developing zebrafish notochord. This secondarily
results in kinking of the notochord that contributes to later vertebral fusions. Furthermore, by
showing that the smyhc1R673H zebrafish model replicates key aspects of the congenital disorder that
can be normalized with myosin inhibitors, we have demonstrated its value for evaluating
therapeutics for use in human DA patients.
2.3 Results
2.3.1 smyhc1R673H is an autosomal dominant mutation that acts in a dose-dependent manner

To study the mechanism by which MYH3 mutations cause DA, we genetically
engineered a mutant zebrafish line in which a single nucleotide substitution was introduced via
homologous recombination into exon 16 using a donor oligonucleotide and TALENs (Figure 2.1AC). The resultant zebrafish smyhc1R673H missense substitution is orthologous to the most common
MYH3 mutation causing DA2A in humans, R672H (Figure 2.1A, B). We concurrently generated
a zebrafish smyhc1-/- line containing a frame-shifting seven base pair deletion that is predicted to
result in a premature truncation in exon 16 and transcript loss by nonsense mediated decay. Indeed,
Smyhc1 protein expression was not detected in smyhc1-/- embryos at 24 hours post fertilization
(hpf) when Smyhc1 is normally most highly expressed in wild-type (smyhc1+/+) embryos (Figure
2.1C-E). In contrast, smyhc1R673H heterozygotes and homozygotes produce detectable Smyhc1
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protein, confirmed via immunohistochemistry staining (Fig 2.1E). The brief period of Smyhc1
protein expression is demonstrated by its absence by 48 hpf in smyhc1+/+ larvae on Western blot
(Fig 2.1D) and in all genotypes by 3 dpf (days post fertilization) as shown by
immunohistochemistry (Supplemental Figure 2.1).

Consistent with prior studies that used morpholinos to transiently reduce smyhc1
expression (Codina et al, 2010), smyhc1-/- embryos displayed no gross phenotype in larval stages
despite being paralyzed until 48 hpf (described below) (Figure 2.2A, 2.5A). In contrast, we noted
that nearly half of the embryos heterozygous for the smyhc1R673H allele displayed mild notochord
kinks or slight curves in the body axis beginning at 48 hpf, while fewer showed more severe kinks,
often in multiple locations along the body axis. Furthermore, all homozygous smyhc1R673H/R673H
zebrafish manifested severely abnormal morphology and developed multiple notochord bends and
kinks that markedly compressed and disfigured the body axis and were apparent by ~30 hpf
(Figure 2.2A, B; Supplemental Figure 2.3A). These early notochord kinks resemble those seen in
the accordion zebrafish mutant, which has a muscle relaxation defect due to a mutation in the
sarcoplasmic reticulum Ca2+ - ATPase pump (atp2a1) (Hirata et al, 2004).
To determine whether the presence of a wild-type copy of smyhc1 influences the phenotype
of fish harboring a single smyhc1R673H allele, we crossed smyhc1-/- and smyhc1R673H/+ mutant lines.
The absence of a wild-type copy of smyhc1 resulted in more severe morphological abnormalities.
In fact, the phenotype of smyhc1R673H transheterozygous embryos (smyhc1R673H/-) was identical to
that of smyhc1R673H/R673H embryos, in which similarly severe notochord kinks and bends were
observed (Figure 2.2A). The observed partial rescue of the smyhc1R673H phenotype via dilution of
the allele with the wild-type allele, and the failure of smyhc1R673H homozygotes, heterozygotes, or
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transheterozygotes

to

phenocopy smyhc1−/− fish

support

the

hypothesis

that

the smyhc1R673H substitution is hypermorphic or neomorphic.
2.3.2 smych1R673H mutation is homozygous lethal and reduces survival of heterozygotes
Because of the disruptive embryonic phenotypes of smyhc1R673H heterozygotes and
homozygotes, we systematically determined the impact of genotype on survival. Because no
smyhc1R673H/R673H individuals survive to adulthood for breeding, we instead incrossed
smyhc1R673H/+ fish, and genotyped the resulting progeny of various ages to determine the ratio of
surviving smyhc1+/+:smyhc1R673H/+:smyhc1R673H/R673H fish (Figure 2.3A). In contrast to the expected
Mendelian ratio of 1:2:1, we discovered that smyhc1R673H/R673H embryos did not survive past larval
stages (Figure 2.3B). We determined that the ratio of smyhc1R673H/R673H embryos sharply declined
between 1 and 2 dpf, with the remaining homozygotes perishing before juvenile stages. Many
smyhc1R673H/+ fish survive into adulthood and are fertile, however survival is reduced compared to
wild type, with a decline continuing throughout adulthood. The smyhc1R673H allele increases
mortality of the fish in a dose-dependent manner, consistent with the severity of the gross
phenotype.
2.3.3 smyhc1-/- adults develop late-onset spinal curvature
We noticed an increase in spinal curvature of smyhc1-/- fish as they reached adulthood, and
decided to examine the phenotype further. Despite the apparent short and early temporal
expression of smyhc1, which is strongly expressed at 24 hpf but markedly reduced by 48 hpf
(Figure 2.1D), its disruption has lasting effects into adulthood. Although smyhc1-/- larvae appeared
morphologically normal (Figure 2.2A), nearly all developed spinal curvatures in adulthood (Figure
2.4A, Supplemental Figure 2.2). To determine whether the observed curvature is associated with
vertebral fusions, alizarin red/alcian blue staining of bone and cartilage, respectively, was
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performed on adult zebrafish between 1 and 2 years old. Alizarin red staining of adult smyhc1-/fish revealed variable spinal curvatures along the length of the spine in both lateral and sagittal
planes (Figure 2.4B). Most smyhc1−/− fish were afflicted with mild-to-moderate curvature
(Figures 2.4C; Supplemental Figure 2.2,3B). Despite the apparent curvature of smyhc1−/− fish,
vertebral fusions were not observed. This is consistent with the lack of notochord abnormalities
displayed in larval stages in smyhc1−/− fish, a phenotype associated with later vertebral fusions in
other mutant fish lines (reviewed in (Ellis et al, 2013a; Ellis et al, 2013b; Gray et al, 2014).
2.3.4 smyhc1R673H/+ adults have both spinal curvature and vertebral fusions
Similar to the smyhc1-/- fish, the smyhc1R673H/+ fish also displayed spinal curvatures in
adulthood, but the fish were often shortened in length (Figure 2.4A; Supplemental Figure 2.2). In
addition, the spinal curves developed much earlier; notochord kinks and bends that were seen as
early as 48 hpf often preceded the later development of structural vertebral abnormalities (Figure
2.2A; Figure 2.4B, much as those previously reported in leviathan/col8a1a zebrafish mutants
(Gray et al, 2014). ). Upon observation of alizarin red stained bone, most smyhc1R673H/+ adults were
found to have moderate-to-severe vertebral abnormalities, with complex and variable vertebral
fusions often involving multiple vertebrae and their jaws often had a closed mouth appearance
(Figures 2.4B, C; Supplemental Figure 2.2,2.3B). Similar to leviathan, the vertebral fusions
in smyhc1R673H/+ were present at regions of severe spinal curve and were not detected in regions
where the spine was straight. Spinal curves were predominantly present in the lateral plane and
were nearly all restricted to the distal tail. However, we noted that some smyhc1R673H/+ larvae with
proximal notochord kinks did not survive to adulthood, which suggests that the propensity toward
distal spinal curves may be due to a selection bias rather than a developmental predisposition to
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data

suggest
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notochord

abnormalities

predispose smyhc1R673H/+ fish to vertebral fusions in adulthood.

2.3.5 smyhc1 mutants have motor deficits

Because smyhc1 is a myosin heavy chain gene critical for motor function, and because of
the observed effects of smyhc1 mutations on gross anatomy described above, we assessed the
effects of smyhc1 mutations on muscle function by quantifying the movement of fish at various
times during development. The smyhc1 gene is expressed embryonically, as early as 10-13 somites
as evidenced by in situ hybridization (Bessarab et al, 2008; Li et al, 2020; Rauch et al, 2003);
therefore, we first assessed embryonic movements by counting the number of light-induced
twitches beginning at 24 hpf when embryos first respond to light stimulation (Kokel & Peterson,
2011; Saint‐Amant & Drapeau, 1998) (Figure 2.5A). The smyhc1−/− embryos were completely
paralyzed up to 48 hpf, after which they exhibited normal movements in response to light
stimulation. There was not a statistically significant difference between smyhc1R673H/+ and their
wild-type siblings until 34 hpf, when mutants displayed a slight decrease in the number of twitches
(Figure 2.5A). At early stages when muscle function was grossly measured as the ability to twitch
in response to light, the smyhc1R673H allele had only minimally apparent effects while lack of
Smyhc1 abolished muscle function in early embryonic stages.

Motor function was also assessed at 6 dpf to determine later effects of smyhc1 mutations
(Figure 2.5B). Automated motion tracking software was used to quantitatively measure
spontaneous swimming distance, which was not possible at earlier stages due to their small size
and transparency. The total distance traveled over 5 minutes was less in smyhc1R673H/+ larvae
compared to their wild-type siblings. The smyhc1−/− larvae swam a significantly shorter distance
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than both of the other genotypes (Figure 2.5B). At larval stages, it appears that the effects
of smyhc1 mutations, even after apparent downregulation of the gene, have an enduring effect on
muscle function and locomotion.

Muscle function was measured in adults at 6 months post fertilization (mpf) by assessing
endurance upon exposure to a gradually escalating flow of water in a swim tunnel (Figure 5C).
The smyhc1R673H/+ fish fatigued in the swim tunnel sooner than smyhc1+/+ and smyhc1−/− fish. No
significant difference was noted in time spent swimming between the smyhc1+/+ and smyhc1−/− fish
(Figue 2.5D). While the smyhc1− allele had a more severe effect on muscle function in larval stages
compared to the smyhc1R673H allele, this result provides evidence that smyhc1−/− mutants recover a
normal degree of motor function in adulthood.

2.3.6 smyhc1 R673H mutants have disorganized muscle and shortened myoseptal intervals

Because smyhc1 is the first and earliest myosin heavy chain expressed in slow skeletal
muscle (Devoto et al, 1996), we examined the effect of mutant smyhc1 alleles on morphological
muscle

development.

in smyhc1+/+, smyhc1−/−,

Phalloidin-rhodamine
smyhc1R673H/+,

and

was

used
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stain

smyhc1R673H/R673H larvae.

filamentous
At
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actin
hpf,

the smyhc1−/− muscle was highly disorganized and had no distinguishable sarcomeres or myofibers
(Figure 2.6A, C). Wavy strands of filamentous actin and numerous puncta of actin bundles were
present (Figure 2.6A). In contrast, smyhc1R673H heterozygotes and homozygotes formed
sarcomeres, but the filamentous actin was unevenly distributed across the myofiber, which
occasionally had a flared appearance near the myosepta (Figure 2.6A). At 3 dpf, discrete
sarcomeres became evident in smyhc1−/− myofibers; however, they were poorly aligned with each
other and with the myosepta. smyhc1−/− larvae were also found to have centralized nuclei (Figure
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2.6B,D). Organized sarcomeres were also present in smyhc1R673H/+ muscle, but myofibers were
thin,

becoming

bulbous

at

their

termini,

leading

to

poorly

defined

myosepta.

The smyhc1R673H/R673H myofibers were also had poorly defined myoseptal boundaries; bundles of
actin were commonly observed (Figure 2.6B,D).

To better define the role of smyhc1 in sarcomere development, Z-disks were labeled with
anti-α-actinin antibodies. At 24 hpf, Z-disks were assembled in smyhc1+/+, smyhc1R673H/+, and
smyhc1R673H/R673H larvae, while smyhc1−/− larvae failed to develop any Z-disk structure (Figure
2.6C). However, by 3 dpf, smyhc1−/− larvae formed Z-disk structures, with a disorganized
appearance consistent with the thin filament morphology (Figure 2.6D). We then quantified the
distance between Z-disks to determine whether sarcomere length was affected by the R673H
mutation or lack of Smyhc1. smyhc1R673H/R673H and smyhc1R673H/+ genotypes displayed
significantly shorter sarcomere lengths compared to wild type at both 24 hpf and 3 dpf, with a
large range of sarcomere length variability in smyhc1R673H/R673H larvae (Figure 2.6G,H). At 3
dpf, smyhc1−/− fish displayed a significantly shorter Z-disk interval than any other genotype.

To determine whether the smyhc1 alleles affected the overall somite length as was
previously observed in the hypercontractile accordion mutant (Hirata et al, 2004), we measured
the distance between myosepta in slow skeletal muscle. Myoseptal intervals were significantly
reduced in smyhc1R673H/R673H and smyhc1R673H/+ muscle at 24 hpf and 3 dpf. smyhc1−/− larvae did
not display a shortened myoseptal distance (Figure 6E,F). Because both the Z-disk interval and
myoseptal interval are reduced in smyhc1R673H mutants, we hypothesize that the shortened
myoseptal interval results from increased tension shortening the length of the sarcomere, and
subsequently the myofiber, as was proposed for the accordion mutant (Hirata et al, 2004).
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Conversely, the shortened Z-disk interval observed in smyhc1−/− fish is not accompanied by a
shortened myoseptal distance. These data, in addition to the observed disorganization of sarcomere
alignment in smyhc1−/− fish, suggest a different mechanism, perhaps in which the structural effects
caused by the lack of Smyhc1 result in both a shortened Z-disk interval and sarcomere
misalignment.
2.3.7 Cell death in smyhc1R673H/R673H zebrafish

To explore the effects of the smyhc1 alleles on cell viability, larvae at 24 hpf and 3 dpf
were stained with Caspase-3 antibodies(Dalgin & Prince, 2015; Dalgin et al, 2011). Increased
signal of the cleaved Caspase-3 protein indicates an activation of the apoptosis pathway (Sorrells
et al, 2013). While there was no difference in cleaved Caspase-3 at 24hpf, smyhc1R673H/R673H larvae
had increased cleaved Caspase-3 in the muscle tissue at 3dpf (Supplemental Figure 2.4). This
suggests that increased tissue stress and muscle cell morphological decline due to
the smyhc1R673H allele may lead to an increase in cell death in the homozygous state.
2.3.8 Para-aminoblebbistatin rescues smyhc1R673H mutant phenotypes
To understand the proposed mechanism and explore new therapeutic approaches to prevent
contractures and disability in DA patients, we evaluated the ability of select pharmacological
agents to normalize the phenotype of smyhc1R673H heterozygous and homozygous embryos.
Tricaine methanesulfonate, an anesthetic that acts as a neuromuscular blocking agent by directly
inhibiting neuronal sodium channels (Attili & Hughes, 2014), was applied to dechorionated
embryos from 12 hpf to 72 hpf. Although the drug completely suppressed embryonic movement
as expected, it failed to improve the ventral body curvature or reduce the development of notochord
kinks in smyhc1R673H heterozygotes and homozygotes (Supplemental Figure 2.5). This suggests
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that the contractures observed in smyhc1R673H mutants arise independently of stimulated muscle
contraction, but may alternatively be intrinsic to the muscle and present even without neural
stimulation.
Myosin ATPase inhibitors are being developed for the treatment of cardiomyopathy caused
by similar mutations of cardiac myosin heavy chain genes (Green et al, 2016), therefore we sought
to determine whether drugs that directly inhibit function of myosin (Kovács et al, 2004) could
reduce the adverse phenotypic effects of the smyhc1R673H allele. Blebbistatin, a myosin ATPase
inhibitor, which reduces actin-myosin affinity, was applied to dechorionated embryos at a
concentration of 25 µM from 24 hpf to 48 hpf (Wang et al, 2015). Blebbistatin prevented the
development of notochord kinks in both smyhc1R673H/+ and smyhc1R673H/R673H embryos (Rauscher
et al, 2018) (Supplemental Figure 2.5B). However, numerous developmental defects, including
pericardial edema, dorsal tail curvature, and small eyes were observed in all fish exposed to this
drug, including wild-type larvae, consistent with the known cytotoxic effects of blebbistatin that
are independent of its myosin inhibition (Várkuti et al, 2016).

A blebbistatin derivative, para-aminoblebbistatin, which is more photostable and less
cytotoxic (Várkuti et al, 2016), was therefore applied to dechorionated embryos at 25 μM for 24
or 48 hours, starting at 24 hpf. While para-aminoblebbistatin does not share the cytotoxic effects
of blebbistatin, its effect on cardiac myosin appears to cause lethal pericardial edema in both
mutant and wild-type embryos (Várkuti et al, 2016). However, similarly to blebbistatin, its effect
on

skeletal

myosin

completely

abolished

notochord

kinks

and

bends

in

both smyhc1R673H/+ and smyhc1R673H/R673H embryos at 2 dpf (Figure 7A). This effect persisted to 3
dpf (Figur 7B). The molecular inhibition of actin–myosin interaction removes the ability of the
muscle to contract. This effect suppresses the smyhc1R673H phenotype, suggesting that the allele
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causes notochord kinking as a secondary effect of constitutive myofiber contraction, independent
of neural stimulation.
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Figure 2.1 Generation of smyhc1 mutant lines and embryonic muscle
development. (A) Schematic to scale of human MYH3 gene on chromosome 17.
Noncoding regions are displayed in pink. Coiled coil domain (840 –1,933 bp)
displayed in purple. Motor domain (86–779 bp) displayed in yellow. Actin
binding site (656–678/758–772 bp) shown in cyan. Location of R672H mutation
is enlarged and labeled. (B) Schematic to scale of zebrafish smyhc1 gene on
chromosome 24. Noncoding regions are displayed in pink. Coiled coil domain
(842–1,929 bp) displayed in purple. Motor domain (85-778 bp) displayed in
yellow. Actin binding site (655–677 bp) displayed in cyan. Location of R672H
mutation is enlarged and labeled. (C) Aligned DNA and amino acid sequences
of MYH3 and smyhc1 alleles surrounding the smyhc1 R673H and MYH3 R672H
substitutions. The smyhc1 − allele has a 7 base pair deletion that results in a
frameshift in which one errant amino acid precedes a premature stop codon.
The smyhc1 R673H allele results from a G>A transition single point mutation. (D)
Western blot of whole zebrafish larvae, Smyhc1 stained with the F59
antibody. smyhc1 +/+ larvae express Smyhc1 at 24 hpf, but not at 48
hpf. smyhc1 −/− larvae do not express Smyhc1. (E) Smyhc1
immunohistochemistry stain of 24 hpf (hours post fertilization) zebrafish larvae.
Filamentous actin is stained with phalloidin (red). Nuclei are stained with DAPI
(blue). Smyhc1 is stained with the F59 antibody (green) (Elworthy et al,
2008). smyhc1 +/+, smyhc1 R673H/+ , and smyhc1 R673H/R673H larvae display Smyhc1
in the muscle fibers at 24 hpf. smyhc1 −/− larvae at 24 do not stain positively for
Smyhc1. Scale bar represents 50 μm.
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Figure 2.2 Embryonic phenotypes of smyhc1 mutants. (A) Morphologies of
smyhc1+/+, smyhc1-/+ and smyhc1-/- embryos are grossly normal at 2 days post
fertilization (dpf), despite complete paralysis of smyhc1-/- embryos. In contrast, the
smyhc1R673H/+ embryos have notochord kinks in larval stages (arrow head), while
smyhc1R673H/R673H embryos have much more severe notochord kinks that compress
and distort the body axis (arrow heads). The smyhc1R673H/- embryos completely
phenocopy smyhc1R673H/R673H embryos. (B) Quantification of smyhc1R673H embryonic
phenotypes at 2 dpf. Representative examples of fish in each of the four phenotypic
groups (normal, mild, moderate, and severe) are shown in Supplemental Figure 2.4.
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Figure 2.3 The smyhc1R673H allele reduces survival in a dose-dependent
manner. (A) Schema of in-crosses used to generate clutches for survival assay. (B)
The predicted mendelian (1:2:1) and experimental ratio of genotypes of progeny
from smyhc1R673H/+ in-crosses demonstrates survival at the indicated ages. This ratio
quickly skewed toward an overrepresentation of smyhc1+/+ fish with no
representation of smyhc1R673H/R673H after 5 dpf. There is also dropout of
smyhc1+/R673H fish into adulthood. Number of fish counted per group is indicated.
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Figure 2.4 smyhc1 mutants exhibit skeletal abnormalities in adulthood. (A)
Gross morphology of smyhc1 mutant adults. Most smyhc1-/- adult fish display dorsal
tail curvature, while smyhc1R673H/+ adults have a shortened body axis and variable
spinal curves. (B) Alizarin red staining of bone shows spinal curvature but no bony
fusions in the skeleton of smyhc1-/- adults, in contrast to the compression and fusion
of vertebrae seen in smyhc1R673H/+ adults. Distal tail regions are highlighted and
enlarged. (C) Quantification of skeletal phenotype severity in adults. Representative
examples of fish in each of the four phenotypic groups (normal, mild, moderate, and
severe) are shown in Fig EV3. Scale bars represent a length of 5 mm.
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Figure 2.5 Motor deficits in smyhc1 mutants are variable during development.
(A) Time course of light-triggered larval movements was manually counted at
indicated times between 24 and 48 hpf. The smyhc1−/− larvae (n = 36) were
paralyzed up to 48 hpf. smyhc1R673H/+ mutants (n = 15) twitched slightly less than
their smyhc1+/+ siblings (n = 21) at 34 hpf. The central bands of the boxplots
represent the median, the boxes of the boxplots represent the interquartile range
(between the first and third quartile), and the whiskers represent the minimum and
maximum values, up to 1.5 times the interquartile range. Outliers displayed are
outside of this range. (B) Distance traveled during 5 min of spontaneous swimming
at 6 dpf quantified by motion tracking software (Noldus Ethovision). At 6 dpf, both
smyhc1−/− (n = 24) and smyhc1R673H/+ (n = 11) larvae traveled significantly less than
smyhc1+/+ larvae (n = 13). The central bands of the boxplots represent the median,
the boxes of the boxplots represent the interquartile range (between the first and
third quartile), and the whiskers represent the minimum and maximum values, up to
1.5 times the interquartile range. Outliers displayed are outside of this range. (C)
Diagram of swim tunnel used to quantify adult swimming behavior. Water flow was
gradually increased until the fish fatigued and were collected at the grate. (D) Time
spent swimming in swim tunnel before fatigue in adults at 6 months post fertilization
(mpf). smyhc1+/+ (n = 6), smyhc1−/− (n = 5), smyhc1R673H/+ (n = 5).
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Figure 2.5 Cont. Data Information: Wilcoxon rank-sum test used to calculate
significance. p-values comparing each group displayed above data. The central
bands of the boxplots represent the median, the boxes of the boxplots represent the
interquartile range (between the first and third quartile), and the whiskers represent
the minimum and maximum values, up to 1.5 times the interquartile range. Outliers
displayed are outside of this range.
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Figure 2.6 Slow skeletal muscle disorganization of smyhc1 mutants. (A) Confocal
fluorescence images of slow skeletal muscle of 1 dpf larvae, stained with phalloidinrhodamine to detect actin. Puncta of filamentous actin are indicated with white
arrowheads, and misshapen myofibers are indicated with white arrows and outlined.
(B) Confocal microscope fluorescence images of slow skeletal muscle of 3 dpf larvae,
stained with phalloidin-rhodamine. Puncta of filamentous actin are indicated with white
arrowheads, distorted myofibers are indicated with arrows and outlined, and frayed
myofibers are indicated with yellow arrowhead. (C)Confocal fluorescence images of
slow skeletal muscle of 1 dpf larvae, stained with phalloidin-rhodamine (red), anti-αactinin antibodies (green), and DAPI (blue). (D) Confocal fluorescence images of slow
skeletal muscle of 3 dpf larvae, stained with phalloidin-rhodamine (red), anti-α-actinin
antibodies (green), and DAPI (blue). Bundle of actin ringed with α-actinin indicated
with white-bordered black arrowhead. (E) Myoseptal intervals of slow skeletal muscle
at

1

dpf

in smyhc1+/+ (n = 54), smyhc1−/− (n = 31), smyhc1R673H/+ (n = 45),

and smyhc1R673H/R673H (n = 49).

Distance

between

myosepta

was

measured

perpendicular to rostral-caudal body axis at defined mid-body regions in phalloidin
stained slow skeletal muscle fluorescence images. The central bands of the boxplots
represent the median, the boxes of the boxplots represent the interquartile range
(between the first and third quartile), and the whiskers represent the minimum and
maximum values, up to 1.5 times the interquartile range. Outliers displayed are outside
of this range.
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Figure 2.6 Cont. (F) Myoseptal intervals of slow skeletal muscle at 3 dpf
in smyhc1+/+ (n = 51), smyhc1−/− (n = 32), smyhc1R673H/+ (n = 64),
and smyhc1R673H/R673H (n = 38). The central bands of the boxplots represent the
median, the boxes of the boxplots represent the interquartile range (between the first
and third quartile), and the whiskers represent the minimum and maximum values, up
to 1.5 times the interquartile range. Outliers displayed are outside of this range. (G) Zdisk

intervals

(sarcomere

length)

of

slow

in smyhc1+/+ (n = 380), smyhc1R673H/+ (n = 293),

skeletal

muscle

at

1

dpf

and smyhc1R673H/R673H (n = 268).

Distance between z-disks was measured in anti-α-actinin stained slow skeletal muscle
fluorescence images. The central bands of the boxplots represent the median, the
boxes of the boxplots represent the interquartile range (between the first and third
quartile), and the whiskers represent the minimum and maximum values, up to 1.5
times the interquartile range. Outliers displayed are outside of this range. (H) Z-disk
intervals

(sarcomere

length)

of

slow

skeletal

muscle

at

3

dpf

in smyhc1+/+ (n = 249), smyhc1−/− (n = 278), smyhc1R673H/+ (n = 246),
and smyhc1R673H/R673H (n = 252). The central bands of the boxplots represent the
median, the boxes of the boxplots represent the interquartile range (between the first
and third quartile), and the whiskers represent the minimum and maximum values, up
to 1.5 times the interquartile range. Outliers displayed are outside of this range.
Data Information: Wilcoxon rank-sum test used to calculate significance. P-values
comparing each group displayed above data. Scale bars represent a length of 50 μm.
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Figure 2.7 Para-aminoblebbistatin ameliorates the smyhc1R673H larval
phenotype. (A) Representative morphologies of smyhc1+/+, smyhc1R673H/+, and
smyhc1R673H/R673H larvae at 2 dpf after 24 hour treatment with 0.25% DMSO (control)
or 25 μM para-aminoblebbistatin. All larvae treated with para-aminoblebbistatin
develop a slight dorsal tail curve and pericardial edema regardless of genotype. All
para-aminoblebbistatin-treated smyhc1R673H/+ (n=9) and smyhc1R673H/R673H (n=3)
larvae are indistinguishable from smyhc1+/+ unlike the untreated larvae which have
markedly curved or distorted body axis. (B) Representative images of smyhc1+/+,
smyhc1R673H/+, and smyhc1R673H/R673H larvae at 3dpf after 48 hour treatment with
0.25% DMSO (control) or 25 μM para-aminoblebbistatin. All larvae treated with paraaminoblebbistatin develop a slight dorsal tail curve and pericardial edema regardless
of genotype. Para-aminoblebbistatin-treated smyhc1R673H/+ (n=9) and
smyhc1R673H/R673H (n=3) larvae are indistinguishable from smyhc1+/+ unlike the
untreated larvae which have markedly curved or distorted body axis.
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2.4 Discussion
Understanding the functional consequences of MYH3 variants associated with human
disease has been limited by the lack of access to human skeletal muscle tissue during embryonic
development. The recent description of multiple human skeletal muscle and bone phenotypes
associated with MYH3 variants, including autosomal dominant and recessive spondylocarpotarsal
synostosis syndromes, in addition to DA, provides a strong motivation to develop animal models
to study and understand these variable phenotypes. By generating two viable zebrafish smyhc1
alleles, including a smyhc1 null allele and a smyhc1R673H missense variant, we now have tools to
assess inheritance models and effects of gene dosage on phenotypic expression.
Our results not only confirm that the smyhc1R673H allele is more severe than a smyhc1 null
allele (which was also recently described in (Li et al, 2020)), but also demonstrate the dosage
sensitivity of the missense allele to the wild-type allele, which modulates the effects of the diseasecausing R673H variant in our model system. Expression of the smyhc1R673H allele in the absence
of a wild-type allele resulted in embryos with a lethal phenotype identical to smyhc1R673H/R673H
embryos. Myosin is comprised of a hexamer containing a pair of heavy chains, a pair of regulatory
light chains, and a pair of essential light chains (Schiaffino & Reggiani, 1996). Because of the
dimerization of the myosin heavy chains, and subsequent assembly of the hexamers into the thick
filament, it is reasonable to hypothesize that compound heterozygosity of a missense mutation in
trans with a hypomorphic or null allele will increase the phenotypic severity of afflicted individuals
compared to a missense mutation in trans with a wild-type allele. In fact, a Dutch study recently
identified a high impact MYH3 5′ UTR variant with a gnomAD minor allele frequency of 0.008
that diminishes MYH3 translational efficiency (Cameron-Christie et al, 2018). This variant was
reported in patients with presumed autosomal recessive spondylocarpotarsal synostosis syndrome,
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demonstrating a biallelic phenotype consisting of a haploinsufficient allele and a hypomorphic
allele. This genotype exacerbated the severity of the disorder, and our results in zebrafish similarly
demonstrate that the phenotypic severity of an autosomal dominant allele is greater when in trans
with a hypomorphic than a wild-type allele. Because intrafamilial phenotypic variability has
previously been reported in DA1 families with MYH3 mutations (Alvarado et al, 2011), we now
hypothesize that expression differences of the wild-type allele may be responsible.
Zebrafish offer many practical advantages for research, including accessibility at early time
points in development due to their optical clarity, speed of development, large clutch size, and
convenient external development. smyhc1 is the only myosin gene expressed during early
zebrafish embryogenesis; therefore, we hypothesized that its manipulation would accurately model
the human condition (Devoto et al, 1996; Elworthy et al, 2008; Schiaffino et al, 2015). Zebrafish
also offer a unique opportunity to study slow skeletal muscle development in isolation due to the
spatial segregation of slow and fast skeletal muscle in zebrafish, with the former developing as a
thin border along the lateral aspect and the latter making up the bulk of the trunk (Elworthy et al,
2008). In contrast, human skeletal muscle is composed of interspersed slow and fast twitch muscle
fibers. Muscle hypercontractility in smyhc1R673H heterozygous and homozygous fish was
evidenced by the shortened slow muscle sarcomere length, and shortened myoseptal interval that
phenocopies the accordion hypercontractile zebrafish mutant which has a muscle relaxation defect
due to a mutation in atp2a1 (sarcoplasmic reticulum Ca2+-ATPase 1)(Hirata et al, 2004). In our
model, some myofibers even appeared to physically dissociate from the myosepta by flaring
bulbously at the end of the myofiber, which we hypothesize was a consequence of excessive
biomechanical

force

and

may

homozygous smyhc1R673H larvae.

have

This

contributed

resembles
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in Drosophila upon expression of the R672C mutation, in which normal myofibril assembly is
followed by degeneration that ultimately results in a complete impairment of flight (Rao et al,
2019).
One of the earliest morphological abnormalities that we observed in smyhc1R673H
heterozygous and homozygous mutant embryos was prominent notochord kinks and bends.
Results from our study suggest that notochord abnormalities arise as a consequence of excessive
tension on the notochord due to hypercontraction and/or uncoordinated contraction of the
surrounding muscle. Data to support this mechanism include the much more severe phenotype
seen in homozygous smyhc1R673H mutants, and the complete rescue of this phenotype by treatment
with the myosin ATPase inhibitor, para-amino blebbistatin. While the notochord abnormalities in
the accordion mutant were suppressed with drugs inhibiting neural transmission (Hirata et al,
2004), the smyhc1R673H mutant notochord defects could not be similarly suppressed, but improved
only when muscle contraction itself was directly impaired via myosin-inhibiting drugs. Our in vivo
results are consistent with prior in vitro studies of both patient muscle tissue and C2C12 cells in
which the R673H variant was observed to negatively affect relaxation kinetics (Racca et al, 2015;
Walklate et al, 2016). As predicted by their work, gross phenotypic abnormalities in our
smyhc1R673H mutants, including severe notochord kinks and bends, were completely abolished
after treatment with myosin inhibitors.
The phenotypic spectrum of MYH3 associated disease was recently broadened to include
vertebral fusions, which are a defining clinical feature of spondylocarpotarsal synostosis
syndrome. Spondylocarpotarsal synostosis syndrome is associated with both autosomal dominant
and recessive inheritance; both missense and nonsense MYH3 variants have been reported in
recessive cases (Cameron-Christie et al, 2018; Carapito et al, 2016; Zieba et al, 2017). Congenital
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spinal fusions were present in our smyhc1R673H mutants but not in smyhc1 null mutant fish,
suggesting that bony fusions in our missense model result secondarily from increased tension
generated by the mutant muscle protein, putting excessive tension and stress on the notochord,
causing it to kink. Gray et al. previously observed a direct spatial relationship between the areas
where notochord kinks were most severe and the location of later developing vertebral fusions in
leviathan/col8a1a null zebrafish (Gray et al, 2014). Thus, our current model supports a
hypermorphic or neomorphic effect of the smyhc1R673H allele that causes increased muscle tension,
which in turn puts excessive stress on the notochord resulting in kinks that progress into vertebral
fusions in adult fish (Figure 2.8). Others have proposed alternative mechanisms for the
development of skeletal abnormalities in MYH3 associated disorders, including a direct effect of
its postnatal expression in vertebral bone (Zieba et al, 2017). Furthermore, the postnatal persistence
of MYH3 expression in the small multifidus muscles connecting to the neural arches of the spine
in mice was also proposed as a possible mechanism. It is possible that abnormal mechanical forces
imposed upon the intervertebral disc by pathogenic MYH3 mutations functioning postnatally in
these small muscle increase the vulnerability of the spine to scoliosis and spinal fusions over time
(Zieba et al, 2017). Furthermore, in cultured cells, MYH3 expression also activates TGF-β
signaling pathways that are associated with bone fusions in other disease models (Zieba et al,
2017). Interestingly, we also note that smyhc1 is expressed in zebrafish somites at the 5-9 somite
stage even prior to muscle development (Bessarab et al, 2008; Li et al, 2020; Rauch et al, 2003);
its role at this early time period is unknown but may indicate a function independent from its role
in muscle. More work is needed to understand the how MYH3 mediates the complex
developmental relationship between muscle and bone.
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Animal models are necessary to advance the development of novel gene-directed therapies
for patients with DA. Pharmacological approaches for DA should be informed by research in
hypertrophic cardiomyopathy on the closely related cardiac myosin heavy chain gene, MYH7
(Green et al, 2016). The R453C variant in MYH7 is analogous to the most common MYH3
mutation in DA2A that we modeled here in the zebrafish gene, smyhc1. Prior work has modeled
the MYH7 R453C variant in mice, demonstrating that treatment with cardiac specific myosin
inhibitors, including the small molecule MYK-461, reduces ventricular hypertrophy,
cardiomyocyte disarray, and profibrotic gene expression that are hallmarks of human hypertrophic
cardiomyopathy (Green et al, 2016). While inhibitors specific for embryonic skeletal muscle
myosin have not yet been reported, they would be ideal drugs for the treatment and prevention of
diseases associated with MYH3 hypermorphic mutations. If MYH3-associated muscle contractures
or bone fusions result entirely from early embryonic gene expression, then short drug treatments
may be sufficient to prevent progression of pathogenic phenotypes. Although our data show that
zebrafish with complete loss of smyhc1 expression have a milder phenotype than those
with smyhc1R673H mutations,

nonspecific

inhibition

of smyhc1 or MYH3 with

antisense

oligonucleotides risks worsening the phenotype of patients with missense mutations, as seen by
the severe phenotype of smyhc1R673H/− mutants. Therefore, any proposed antisense oligonucleotide
therapy would need to be designed specifically for each MYH3 pathogenic variant. Our work
supports the potential use of myosin ATPase inhibitors for the treatment of MYH3-associated DA,
but considerable challenges remain, including elucidation of the optimal treatment period and
reduction of toxicity through the development of embryonic myosin specific inhibitors.
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2.5 Synopsis
2.5.1 Problem
The debilitating joint contractures that are characteristic of distal arthrogryposis (DA)
syndromes are currently suboptimally treated with supportive care. Understanding how dominant
or recessive MYH3 mutations cause contractures or bony fusions has been limited by poor access
to human tissue, particularly during early development when MYH3 is most highly expressed.
Previous single-cell and small molecule studies suggest that DA mutations cause muscle
hypercontraction, but vertebrate models are required to study the complex interactions between
bone and muscle and to develop novel targeted therapeutics.
2.5.2 Results
Zebrafish carrying a single copy of the most common DA-associated MYH3 substitution
(R672H) displayed notochord bends that developed into scoliosis and vertebral fusions in
adulthood, as well as shortened muscle fibers and impaired swimming capacity. The direct
chemical inhibition of muscle contraction with the myosin ATPase inhibitor paraaminoblebbistatin prevented the notochord bends from developing in both heterozygous and
homozygous fish, suggesting that the mutant allele causes notochord and vertebral abnormalities
through a mechanical increase in muscle tension.
2.5.3 Impact
We developed a viable zebrafish model of DA that is dually useful for both mechanistic
studies and therapeutic drug development. Our demonstration that the muscle hypercontractility
mediated by the MYH3 mutation secondarily leads to vertebral fusions highlights the
interconnectedness of the muscular and skeletal systems during early development. Furthermore,
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we have shown the beneficial effects of myosin ATPase inhibitors for the treatment of DA (Figure
2.8).
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Figure 2.8 Synopsis Schematic. Introduction of the most common distal
arthrogryposis (DA) associated pathogenic missense variant (MYH3R672H) into the
analogous zebrafish gene (smyhc1R673H) largely reproduced the human phenotype.
This model of provides key mechanistic insight into the pathogenesis of
developmental disorders of muscle and bone as well as exploration of novel
therapeutics. Here, we show Smyhc1R673H causes muscle hypercontraction, which
deforms muscle (shortening muscle fiber length). Tension caused by the
hypercontracted muscle bends the notochord early in development, which develop
into vertebral fusions and scoliosis. By reducing the hypercontracted state, myosin
ATPase inhibitors normalize the notochord phenotype and show promise for human
therapeutics.
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2.6 Supplemental figures

Supplemental Figure 2.1. Transient expression of smyhc1. Smyhc1
immunohistochemistry stain of 3 dpf zebrafish larvae. Filamentous actin is
stained with phalloidin (red). Nuclei are stained with DAPI (blue). Smyhc1 is
stained with the F59 antibody (green)
(Elworthy et al, 2008). smyhc1 +/+, smyhc1 R673H/+ , and smyhc1 R673H/R673H larvae
do not display Smyhc1 in the muscle fibers at 3dpf. Data Information: Scale
bar represents a length of 50 μm.
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Supplemental Figure 2.2. Examples of adult phenotypes resulting from various
smyhc1 mutant genotypes.
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Supplemental Figure 2.3 Representative examples of each embryonic and
adult graded phenotype. (A) Grading scale for 2 dpf embryos. Normal is classified
as 0 visible abnormalities, mild is classified as 1 notochord curve or kink, moderate
is classified as multiple notochord curves or kinks, and severe is classified as
multiple notochord kinks that severely distort the body. Arrowheads indicate
notochord abnormalities. (B) Grading scale for adult skeletal abnormalities. Normal
is classified as 0 visible abnormalities, mild is classified as 1 spinal curve or kink,
moderate is classified as multiple spinal curves or kinks, or apparent vertebral
fusion, and severe is classified as multiple spinal kinks or vertebral fusions that
severely distort the body. Arrowheads indicate spinal abnormalities.
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Supplemental Figure 2.4 Activated Caspase-3 presence in smyhc1 mutant
tissue. (A) Confocal fluorescence images of slow skeletal muscle of 1 dpf
larvae, stained with phalloidin-rhodamine (red), Caspase-3 antibodies (green),
and DAPI (blue). (B) Confocal fluorescence images of slow skeletal muscle of
3 dpf larvae, stained with phalloidin-rhodamine (red), Caspase-3 antibodies
(green), and DAPI (blue).
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Supplemental Figure 2.5 Tricaine fails to ameliorate the smyhc1R673H larval
phenotype, and blebbistatin improves the smyhc1R673H larval phenotype. (A)
Zebrafish embryos (2 dpf) treated with 40 mg/ml tricaine methanylsulfonate or
control egg medium for 24 h starting at 1 dpf. Tricaine suppressed movement
but failed to normalize notochord kinks and bends. Tricaine appears to have no
major effect on anatomy. (B) Zebrafish embryos (2 dpf) were treated with 25 μM
blebbistatin or DMSO control for 24 h starting at 1 dpf. Blebbistatin appears to
partially rescue smyhc1 R673H phenotype, but causes known off target effects.
Note the severe dorsal tail curve and pericardial edema present in all larvae
treated with blebbistatin regardless of genotype. Representative images of
embryos at 48 hpf.
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2.7 Materials and methods
2.7.1 Ethical statement
Husbandry and protocols for experiments involving zebrafish (Danio rerio) have been
reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) at
Washington University.
2.7.2 Zebrafish husbandry
Zebrafish (Danio rerio) were raised and maintained using standard methods (Westerfield,
1995). Zebrafish were housed and handled using protocols approved by the Institutional Animal
Care and Use Committee (IACUC) at Washington University.
2.7.3 TALEN (Transcription activator-like effector nuclease) generation of smyhc1 mutants
Left and right TALENs were designed to target the sites flanking codon 673 of smyhc1, on
exon 16. TALENs were generated using the Golden Gate method as previously described (Cermak
et al, 2011). Plasmids were acquired from the Golden Gate TALEN and TAL Effector Kit
(AddGene) and RVD repeat arrays were cloned into pCS2TAL3DD and pCS2TAL3RR
(AddGene). Plasmids were transformed into DH5α competent cells (Invitrogen) and isolated using
the QIAprep Spin Miniprep Kit (Qiagen).
Subsequently, plasmids encoding the scaffold and RVD arrays were linearized via
restriction digest and 5′‐capped mRNA was generated by in vitro transcription using the
mMESSAGE mMACHINE SP6 Transcription Kit (Life Technologies). Capped mRNA was
purified using the RNeasy Mini Kit (Qiagen). WT embryos were collected, and 40–50 pg of pooled
left and right TALENs at equal concentrations were injected into the yolk of 1-4 cell stage
embryos. Embryos were raised to adulthood, and sperm and progeny of these fish were collected
and sequenced with MiSeq to screen for germline transmission.
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2.7.4 Western blot of Smyhc1 protein
For each sample, 20 embryos were collected and dechorionated in a 37°C 1 mg/mL
pronase egg water solution. Embryos were deyolked by agitating in deyolking buffer (55mM NaCl,
1.25 mM NaHCO3, 1.8 mM KCl, 2.7 mM CaCl2). Embryos were then washed twice in wash buffer
(10 mM Tris pH 8.5, 110 mM NaCl, 3.5 mM KCl, 2.7 mMCaCl2). Embryos were then agitated in
RIPA with complete protease inhibitor cocktail (Roche Applied Sciences). 50 µg of each sample
was loaded onto a sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–PAGE).
Proteins were transferred to PVDF transfer membrane (Immobilon) for immunoblotting.
Membranes were blocked in 5% skim milk for 1 hour and incubated with antibody in 1% skim
milk overnight at 4°C. The embryonic myosin heavy chain antibody (F59)(Elworthy et al, 2008)
(Developmental Studies Hybridoma Bank) was used to stain Smyhc1. A GAPDH antibody
(Thermo Scientific) was used as a loading control. Membranes were washed in 0.1% PBST (0.1%
Tween-20 in PBS) and incubated with a secondary anti-mouse antibody conjugated to horseradish
peroxidase and developed with a chemiluminescent substrate enhanced chemiluminescence (GE
Healthcare).
2.7.5 Genotyping of smyhc1R673H mutants
Individual fish were genotyped via PCR amplification of the smyhc1 mutant region, with
subsequent restriction digest targeting to identify the R673H allele. DNA was extracted from tissue
samples in lysis buffer (0.1M Tris, 0.005M EDTA, 0.03% SDS, 0.2 M NaCl, 1% Proteinase K
[New England Biolabs, P8107S]), incubated at 50°C for 16 hours, and 95°C for 10 minutes. A
fragment of DNA containing the R673H mutation was PCR amplified. The amplified DNA was
incubated with the restriction enzyme ApaLI in CutSmart buffer (New England BioLabs; R0507S,
B7204S) for 16 hours at 37°C, which cleaves smyhc1 R673H mutant DNA fragments, allowing
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wild-type, homozygous, and heterozygous individuals to be identified after separation on an
agarose gel.
2.7.6 Alizarin red/Alcian blue skeletal staining
Adult zebrafish (1–2 years postfertilization, male and female) were euthanized and fixed
in 4% paraformaldehyde in PBS at room temperature under agitation for 7 days. They were then
incubated in acetone overnight under agitation at room temperature. After rinsing in water, they
were then incubated overnight under agitation in staining solution (0.015% Alcian Blue, 0.005%
Alizarin Red, 5% Glacial Acetic Acid, 59.5% Ethanol). The fish were rinsed once and then for
30 min under agitation at room temperature in water. The fish were incubated in 1% KOH under
agitation at room temperature until the soft tissue became transparent, 1–3 weeks depending on
the size of the fish. The 1% KOH solution was replaced periodically. The fish were stored in
glycerol, and the scales removed manually if they had not fallen off during KOH clearing.
2.7.7 Phalloidin-rhodamine/DAPI/Immunohistochemistry muscle staining and imaging
Zebrafish larvae 1–3 dpf were euthanized and fixed in 4% paraformaldehyde in PBS
overnight under agitation at 4°C. The larvae were washed briefly and then twice for 30 min in
PBD (0.1% Tween-20, 0.3% Triton X-100, 1% DMSO in PBS) under agitation at room
temperature. The embryos were then incubated in block solution (0.1% Tween-20, 10% FBS, 2%
BSA) at room temperature under agitation for 60 min. Primary antibodies were added to the block
solution at the appropriate dilutions [F59 (Iowa Developmental Studies Hybridoma bank) 1:10;
anti-Caspase 3 (Sigma-Aldrich AB3623) 1:100; anti-α-actinin (Sigma-Aldrich A7811) 1:800; antiphospho-SMAD2 (Sigma-Aldrich AB3849) 1:100] and incubated overnight under agitation for
4°C. The solution was removed, and the embryos were washed once quickly in PBD and twice for
30 min under agitation at room temperature. The embryos were then incubated in block solution
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for 60 min under agitation at room temperature. The appropriate secondary antibody was added to
the block solution [Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (Abcam ab150077) 1:500,
Goat Anti-Mouse IgG (H&L) (Adsorbed Against: Hu., Bv., Hs.) (DyLight® 488) (Leinco M1331)
1:500], and the embryos were incubated at 4°C overnight under agitation in the dark. The solution
was removed, and the embryos were washed once quickly in PBD and incubated with DAPI
(Sigma-Aldrich D9542) at a dilution of 1:15,000 in PBST for 30 min under agitation at room
temperature. The solution was removed, and the embryos were incubated in rhodamine phalloidin
(Invitrogen 2009720) at a dilution of 1:1,000 in PBD for 30 min at room temperature. The embryos
were then washed in PDB for 30 min at room temperature and mounted on slides in glycerol under
cover slips before imaging under confocal microscopy. Confocal images of stained muscle were
analyzed in ImageJ to measure myosepta distance.
2.7.8 Microscopy
Confocal images were taken on an Olympus BX61WI fixed stage microscope with
Olympus Fluoview FV1000 confocal laser scanning. Images were processed in ImageJ.
2.7.9 Drug treatment
Embryos were dechorionated prior to drug treatment. Embryos were immersed in 40 ug/mL
tricaine methanesulfonate in egg water (5 mM NaCl, 0.17 mM KCl, 0.33 mm CaCl 2, MgSO4 in
H2O), 25 uM blebbistatin, or 25 uM para-aminoblebbistatin. Para-aminoblebbistatin in DMSO was
mixed with egg water to facilitate dissolution of blebbistatin in aqueous buffer, generating 0.25%
DMSO, 25 uM blebbistatin in egg water. For the tricaine treatment, the egg water was replaced
every 24 hours for 5 days. All incubations were performed in glass-bottom dishes. Images of the
embryos were taken periodically.
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2.7.10 Noldus movement quantification
The Noldus DanioVision and EthoVision software were used to record and quantify
movement of zebrafish larvae at 6 dpf. Larvae were acclimated in the DanioVision box for 5–
10 min before using swimming data for analysis. Embryos were loaded into the DanioVision in
12-well cell culture plates in replicates and placed in wells at random. Five minutes of recorded
behavioral data was analyzed for the distance traveled. The EthoVision software tracked and
recorded fish movement data.
2.7.11 Light stimulated motor activity
Light stimuli were administered to zebrafish embryos which were individually embedded
in their chorions in an agarose mold. They were kept in an opaque box in a 28.5oC incubator
between timepoints. At 17, 21, 24, 26, 28, 30, 32, 34 and 48 hpf, each mold was placed on a
dissecting microscope stage, and a video recording was captured. The embryos were subjected to
two cycles of 30 seconds in the dark and 30 seconds under light stimulus, with a final 30 second
dark period afterwards. The number of times each embryo twitched was counted in each recording.
2.7.12 Swim tunnel quantification
Zebrafish were loaded into a swim tunnel with a steadily increasing flow. Once an
individual fish fatigued, it lay against the back grate of the tunnel and was removed from the
experiment to a separate tank, and the time to fatigue was recorded. After acclimating with no
flow, the fish were subjected to 10 cm/s flow for 1 min. The flow then increased by 2 cm/s every
minute until every fish fatigued.
2.8.13 Statistical analysis
Differences in number of twitches, distance traveled, α-actinin intervals, and myoseptal
intervals were quantified using nonparametric tests (Wilcoxon rank-sum test), so normal
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distribution was not assumed in the statistical tests. An estimate of variation was not included in
the statistical analysis, but seems to vary between compared groups. R was used to analyze data
and generate graphs.
Sample size was determined based on experience from previous findings and animal
availability. Depending on the nature and complexity of the assay, the maximum number of
animals that could be tested was used to increase statistical power as much as possible. No samples
were excluded from analysis. Zebrafish were chosen at random as subjects before genotype was
determined. When determining survivability of zebrafish genotypes, entire clutches were
genotyped to avoid selective bias. The investigator was not blinded before assessing skeletal,
muscular, or gross anatomical abnormalities of zebrafish.
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Chapter 3: A higher-throughput method of targeted
mutagenesis to functionally test variants in vivo
3.1 Abstract
While inducing a targeted deletion into the genome using CRISPR is straightforward and
efficient, insertion of a mutation via homologous recombination is much less probable and often
out of frame. As discussed previously, we generated an smyhc1R673H zebrafish line to functionally
test the variant in vivo. However, to create this stable line, thousands of zebrafish embryos were
injected and screened before germline transmission was detected. To identify our founder with the
correct single base pair substitution, we genotyped the gametes of many individual F0 fish, which
was very time and labor intensive. Many SNPs are reported in human patients. However, without
an in vivo model, it is difficult to functionally test the pathogenicity and functional effects of these
mutations. Using the previous method to produce and test these variants is unfeasible. Therefore,
a higher throughput method of mutagenesis is necessary. We developed a plan to create a founder
zebrafish line that would allow us to easily detect embryos in which an in-frame knock-in had
occurred. Specifically, we inserted a GFP tag to the end of smyhc1 and deleted a coding region of
interest, where many SNPs cluster. This knocks the GFP out of frame, ceasing expression of GFP.
The deleted region provides a location for introducing new single nucleotide variants. Upon
accurate recombination and insertion of a variant in frame, the GFP will be become in frame,
inducing GFP expression as a reporter that enables efficient screening of F0 embryos. This may
drastically streamline the process of generating missense mutants in a gene of interest in zebrafish,
allowing for functional testing of many variants of unknown significance.
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3.2 Introduction
Identification of variants in a candidate disease gene is an important step in diagnosis, and
can improve our understanding of the development of congenital disorders (van der Sijde et al,
2014). Guidelines have been established to help estimate the probability of pathogenicity for
clinical variant interpretation. First, the allele frequency of a variant in the general population can
be used to is an indication of variant pathogenicity. Evolutionarily, it is well known that rare
variants are more likely to be detrimental than common ones, as those have undergone selection
and would have been bred out of a population if deleterious. Second, segregation of a variant with
disease phenotype increases the confidence that a given variant is linked with a specific congenital
disorder. Modeling can also be used to predict the effect of a SNP on protein structure, stability,
and chemical properties (Ioannidis et al, 2016; Kircher et al, 2014; Rentzsch et al, 2019; Thusberg
et al, 2011; Visscher et al, 2012). However, these computational methods are limited in
determining the functional effect of variants on protein behavior, how they interact with other
proteins, and the effect on cell structure and tissue as a whole. Thus, the gold standard is often to
test the functionality of a gene variant in vitro or in vivo.
Direct comparison of wild type and mutant gene function is crucial to understanding the
mechanisms by which genetic variants cause congenital phenotypes. In vitro testing can examine
chemical properties of wild type and mutant proteins, including ATPase activity and interaction
with ligands (Echwald et al, 2002; Han et al, 2000; Racca et al, 2015; Silva et al, 2012; Walklate
et al, 2016). However, when genes have non-cell autonomous effects, in vivo assays may be more
useful in exploring a disease mechanism. For example, a vertebrate model is necessary to
understand how a gene expressed in muscle may affect skeletal development and morphology. In
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addition, in vivo assays allow us to test allele dosage effects, as well as functional effects of
interaction between wild type and SNP mutant proteins.
Functional testing of MYH3 variants is especially important due to the large number of
variants of uncertain significance reported in ClinVar (Table 3.1). Many missense mutations in
MYH3 are reported in association with DA and other musculoskeletal disorders, but the mechanism
by which these different variants alter protein function and lead to disease phenotype has not been
robustly explored.
Development of bone, joints, and muscle are interlinked, and the full effect of mutant
MYH3 function is difficult to study without established vertebrate models. Patient tissue is scarce,
and in vitro methods of protein and tissue characterization are incomplete, as the skeleton is
necessary in the model to fully grasp the mechanism by which these mutations alter joint and bone
structure. To functionally test the effects of a reported MYH3 variant, we generated a zebrafish
model for a missense mutation commonly associated with DA (smyhc1R673H) (Whittle et al, 2020).
While we were able to characterize the muscle structure and function, and later reverse the disease
phenotype, this represents only one example of a pathogenesis mechanism of a DA variant. The
current methods for generating mutant lines with single nucleotide variants, such as this,are not
very efficient, and most are both time and labor intensive.
Here, we outline a method for higher throughput variant generation in zebrafish using a
GFP reporter. GFP is inserted at the end of the smyhc1 gene, and subsequently knocked out of
frame as a region of interest in smyhc1 is removed. Upon accurate in-frame repair with a template
containing a single nucleotide variant, the GFP will again be in frame, which allows efficient
screening of F0 embryos for successful variant integration. This strategy will allow us to
functionally test a broad array of mutations much more efficiently.
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Table 3.1 MYH3 variants reported in ClinVar. Many missense variants of unknown
significance have been reported in MYH3. (Accessed on ClinVar 10 August 2022)
Pathogenicity
Benign

Missense Nonsense
15
0

Frameshift Splice site UTR
0
0
1

Likely Benign

24

0

0

0

1

Uncertain Significance

141

6

2

2

2

Likely Pathogenic

20

3

5

6

0

Pathogenic

10

2

0

5

0

Conflicting Interpretations

29

1

1

1

2

Total

239

12

8

14

6
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3.3 Generation of smyhc1-2A-GFP mutants
Initial generation of smyhc1-C-terminal GFP fusion mutants yielded a homozygous lethal
allele (data not shown). GFP protein tags have been previously observed to alter protein function
(Oshikane et al, 2018). There are also cases described where the location of a GFP tag has differing
effects on protein localization and cell fitness (Skube et al, 2010; Weill et al, 2019). Because this
protein dimerizes and bundles into thick filaments, it is possible that the GFP tags affected function
when congregated into these large complexes. It is also possible that the tag altered localization of
Smyhc1. Being such a large protein, (1969 residues, 226.78 kDa [Ensembl]), errant localization
could have drastically deleterious effects on the cells and tissue. Furthermore, as seen in our
smyhc1R673H mutants, alteration of the function of this gene may also result in homozygous
lethality.
Any phenotype causing homozygous lethality will likely confound the phenotype we
attempt to observe in our induced missense mutants. Therefore, we pursued a new construct with
a 2A self-cleaving peptide linker between smyhc1 and GFP at the C terminus, resulting in cytosolic
GFP in cells expressing Smyhc1 (allele smyhc1-2A-GFP) (Figure 3.1, 3.2) (Donnelly et al, 2001;
Minskaia et al, 2013; Ryan et al, 1991). We expect that this will eliminate the lethality that occurred
with GFP directly added to the C-terminus of Smyhc1.
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Figure 3.1 Expression of GFP in smyhc1-2a-GFP zebrafish larvae. smyhc1-2AGFP F0 mosaic fish were crossed to wild-type. Comparison of resulting smyhc1-2AGFP / smyhc1+ F1 larva (right) and wild-type sibling (left).
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Figure 3.2 Effect of inclusion of 2A peptide self-cleaving linker between
smyhc1 and GFP. The original construct yielded a Smyhc1 protein that we tagged
with GFP at the C-terminus (left), vs the 2A peptide linker, which still allows both
Smyhc1 and GFP to be translated from the same transcript, but enables cleavage of
GFP from Smyhc1, resulting in cytosolic GFP.
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3.4 Future directions
We plan to use these zebrafish mutant lines to more efficiently induce and screen for
variants of interest in exons 2-12 of smyhc1, the MYH3 analog in fish (smyhc1). This collaborative
effort between the Christina Gurnett and Aaron Johnson labs will be continued by other lab
members because the lengthy breeding strategy necessary to complete this project was outside the
scope of this thesis.

3.4.1 Future method of high-throughput screening for in-frame mutagenesis
With the GFP reporter, we can efficiently screen for in-frame variant integration. Because
pathogenic variants cluster in the motor domain of MYH3, we plan to target the analogous region
of smyhc1 for variant testing. This region of interest, encoded by exons 2-12, will be knocked out
via a 2-guide CRISPR approach. This will generate a large deletion and frameshift in smyhc1, and
also put the GFP out of frame (allele smyhc1-2A-GFP del).
Once this knockout (smyhc1-2A-GFP del) is established as a stable line, we will design a
single CRISPR gRNA to target the deletion site. Co-injecting a CRISPR cocktail with this gRNA
and a repair vector including a variant of interest will induce in-frame integration of the variant at
some efficiency (Table 3.2). This accurate in-frame insertion will also put the GFP into frame.
Fish with successful integration can be efficiently screened via GFP expression for analysis (Figure
3.3). Fish with high GFP expression (many cells expressing GFP) are more likely to have germline
integration of the variant as well.
The benefit of this approach is the ability to screen F0 embryos for correct homologous
repair. Using the older, previously described method of variant mutagenesis, all F0 fish needed to
be grown to adulthood to test for successful in-frame integration of a variant in the germline via
high-throughput sequencing. Using this new innovative method, not only are F0 fish able to be
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screened much sooner, but we can also detect individual cells with apparent in-frame insertion.
Therefore, there is the potential for phenotype analysis in the F0 mosaic fish as well.
3.4.2 Future method of F0 variant phenotype analysis using GFP reporter
We can specifically target the smyhc1-2A-GFP del allele by designing a gRNA targeting the
newly created deletion site. smyhc1-2A-GFP del / smyhc1+ heterozygotes can be injected with this
gRNA and a repair vector in a CRISPR cocktail, where only the smyhc1-2A-GFP del allele will be
targeted. Cells where this variant integration is successful will express GFP, allowing these cells
to be examined individually for a heterozygous phenotype (Figure 3.4).
In embryos, slow muscle cells where smyhc1 is expressed are mononucleate (do not fuse
together), ensuring that green cells are not resulting from leaked GFP from neighboring cells
(Hromowyk et al, 2020; Shi et al, 2017).
Previously, we observed significantly altered muscle morphology in our previously
described heterozygous smyhc1R673H/+ mutants. The individual muscle fibers of these mutant fish
were malformed with shortened sarcomeres as early as 1 dpf (Whittle et al, 2020). In addition,
DA-associated MYH3 variants are almost always de novo heterozygous mutations in human
patients (Beck et al, 2013; Scala et al, 2018; Toydemir et al, 2006; Zhao et al, 2022). This suggests
that the GFP-expressing smyhc1-2A-GFPVoI / smyhc1+ cells that we generate in F0 fish may have
pathogenic muscle phenotypes even at early stages of development.

73

Figure 3.3 Workflow schematic of high throughput variant mutagenesis and
screening. A GFP reporter is inserted to the end of smyhc1. Region of interest is
removed via CRISPR using two gRNAs and non-homologous end joining (NHEJ). A
gRNA targeting the deletion site is co-injected with a repair template containing a
variant of interest (VoI). In-frame homology-directed repair (HDR) integrating the
repair template sequence will put the GFP back into frame, allowing for efficient
screening of F0 embryos.
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Figure 3.4 Workflow schematic of F0 heterozygous variant phenotype analysis
in mosaic larvae. After outcrossing smyhc1-2a-GFPdel/del homozygotes to smyhc1+/+,
we can target the smyhc1-2a-GFPdel allele for CRISPR mutagenesis. When coinjected with a repair template containing a variant of interest, the smyhc1-2A-GFP
allele will be cut at the region of deletion, allowing for homology-directed repair (HDR)
integrating the repair template into the allele. Upon in-frame integration of the
template, the GFP will be knocked into frame at some level of efficiency. The mosaic
embryos will express GFP in cells with in-frame integration of the repair template.
These GFP-expressing cells can be examined and characterized in an efficient
analysis of F0 embryos.
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Table 3.2 Candidate variants for functional testing. (Toydemir et al 2006), ClinVar

MYH3
Variant
P83R

Pathogenicity
Conflicting reports

Analogous
smych1 mutation
P82R

Associated disease
DA2A, DA2B

Accession #
VCV000321773

M91L

NA

Likely pathogenic

M90L

VCV000452380

T178I

DA2A, DA2B

Pathogenic

T177I

VCV000014140

S261F

DA2B

Likely pathogenic

S259F

VCV000694358

S292C

DA2B

Conflicting reports

S290C

VCV000211557

M363L

HCM

Likely benign

M361L

VCV000220731

E375K

DA2B

Conflicting reports

E373K

VCV000014143

Y387C

DA2B

Pathogenic

Y385C

VCV000631471

R404T

DA2A,DA2B

VUS

R402T

VCV000321762

D462G

DA2B

VUS

D460G

VCV000014144
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3.5 Materials and methods
3.5.1 Ethical statement
Husbandry and protocols for experiments involving zebrafish (Danio rerio) have been
reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) at
Washington University.
3.5.2 Zebrafish husbandry
Zebrafish (Danio rerio) were raised and maintained using standard methods (Westerfield,
1995). Zebrafish were housed and handled using protocols approved by the Institutional Animal
Care and Use Committee (IACUC) at Washington University.
3.5.3 Generation of smyhc1-2A-GFP Zebrafish Mutants
We used a dual gRNA approach for this CRISPR protocol (dgRNA). 10 uL of 100 µM AltR ® tracrRNA (IDT 1072534) was added to 10 uL 100 uM crRNA (IDT custom [/AlTR1/rArA
rCrA rArA rCrA rArA rCrU rCrG rUrU rArU rArC rGrU rUrU rUrA rGrA rGrC rUrA rUrG
rCrU/AlTR2/]). This was incubated at 95 oC for 5 minutes, then cooled to 25 oC at a rate of -0.1
o

C/second. It was kept at 25 oC for 5 minutes, then stored at -20 oC in 1 uL aliquots (50 uM). 1 uL

dgRNA, 1 uL Cas9 protein (25 uM), 0.5 uL phenol red, and 2.5 uL KCl (300 mM), were mixed
and incubated at 37 oC for 5 minutes. Next, 2 uL smyhc1_2A_GFP (100 ng/uL) repair vector and
1 uL NU7441 (400 mM) were added. This cocktail was injected into 1-cell stage zebrafish
embryos.
Embryos were screened between 1 and 5 dpf for GFP expression in F0 and F1 embryos.
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Chapter 4: FNDC1-associated scoliosis and zebrafish model
4.1 Preface
Parts of this chapter were adapted from the following manuscript:
Antunes, L., Haller, G., Whittle, J., Avery, A., Morcuende, J.A., Giampietro, P. , Raggio,C. ,
Hadley-Miller, N., Strande, N.T., Seeley, M., Bodian, D.L., Sepich, D. , Dobbs, M.B., Gurnett,
C.A.“Severe adolescent idiopathic scoliosis is associated with ultra-rare missense variants in
FNDC1 and other core matrisome genes.” In Preparation
Author Contributions:
LA and CAG designed the study and wrote the manuscript. LA carried out data processing and
statistical analysis. LA, GH and CAG analyzed and interpreted the statistical results. LA, JW, and
CAG designed the laboratory experiments (zebrafish work). NTS and BLD performed and
interpreted all analyses pertaining to the Geisinger dataset. MS reviewed scoliosis phenotypes and
ICD codes extracted from the Geisinger HER. All authors reviewed and approved the final version.
4.2 Abstract
Adolescent idiopathic scoliosis (AIS) is the most common pediatric spinal deformity. Major spinal
fusion surgery is often required for patients with progressive AIS. Although this disorder runs in
families, the genetic risk factors for severe disease are largely unknown. To explore the role of
rare variants in severe AIS, a gene burden analysis of 1,221 cases revealed an enrichment of ultrarare missense variants in core matrisome genes (p=7.19 x 10 -5, OR =1.1). Most significant
enrichment was observed in fibronectin type III domain containing 1 (FNDC1), which was
previously associated with joint hypermobility. We found FNDC1 harbored variants in 3.9% of
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AIS cases compared to 1.8% of controls (p=6.63 x 10-4, OR=2.2). The association of FNDC1 rare
variants with scoliosis replicated in the Geisinger MyCode cohort (p=0.0002, OR=3.6). To explore
the functional effects of FNDC1 deficiency, we characterized an fndc1 zebrafish mutant. While
we did not observe a gross phenotype, disruption of the fndc1 locus in zebrafish caused
abnormalities in the vertebrae. MicroCT analysis revealed increased bone mineral density, crosssectional area, and altered the pMOI score, suggesting a possible mechanism of pathogenesis. In
summary, our data implicate FNDC1 as a novel gene contributing to severe AIS and support a key
role for core matrisome gene variation in scoliosis pathogenesis.
4.3 Introduction
Scoliosis is the most common pediatric spinal deformity. In more than 80% of patients,
scoliosis is idiopathic and appears during adolescence. Commonly referred to as adolescent
idiopathic scoliosis (AIS), it presents without any apparent congenital spinal deformities. Risk
factors for curve progression include curve type, age, sex, and lack of joint hypermobility
(Czaprowski, 2014; Czaprowski et al, 2011; Miller, 1999). Although this disorder runs in families,
the genetic factors that contribute to severe idiopathic scoliosis are largely unknown.
To identify genetic risk factors for severe AIS, we generated whole exome sequence (WES)
data from a large multicenter cohort of 1,221 cases with severe AIS, defined as spinal curvatures
>35 degrees. Here, we performed burden analyses to investigate the genetic contribution of ultrarare missense variants and identified a strong association of variants in FNDC1 and other core
matrisome extracellular matrix genes with AIS.
Following this discovery, we then examined fndc1 nonsense mutant zebrafish to determine
how this gene may contribute to AIS progression. We observed no gross phenotype in the fish,
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and performed further analysis with microCT. Here, we found subtle differences in the vertebrae
between fndc1 mutants and their wild type siblings. While we did not observe a scoliosis phenotype
in our model, our findings suggest alterations in vertebral bone structure may act as risk factors
for scoliosis progression in human patients.
4.4 Results
4.4.1 Study samples and quality control
To identify the role of genetic variants in severe AIS susceptibility, we generated and
analyzed whole exome sequence (WES) data from a multicenter cohort of unrelated individuals of
European ancestry with severe juvenile or adolescent-onset idiopathic scoliosis, defined as a Cobb
angle of at least 35 degrees. Overall, this severe AIS cohort was 84% female and had a mean Cobb
angle of 55° and a mean age of 23.8 years (Supplemental Table 4.1). In-house control WES data
was generated using the same methodologies and consisted of individuals who were ascertained
for conditions other than scoliosis, including 83% with Alzheimer’s disease or amyotrophic lateral
sclerosis.
Following WES data processing and quality control, we analyzed data from 2,618
unrelated individuals of European ancestry that included 1,221 severe AIS cases and 1,397 inhouse controls that were matched by ancestry. Multiple steps were taken to minimize spurious
associations, including: (1) joint processing of read alignment, variant calls, variant QC, and
annotation for AIS cases and in-house controls using the same methods and tools; (2) confirmation
of genetic ancestry homogeneity using principal component analysis; (3) confirmation that all
individuals were unrelated using pairwise relationship analysis; and (4) control for potential
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confounders, including Hardy Weinberg equilibrium, genotype call rate and missingness (Data not
shown).
4.4.2 Rare variants in core matrisome genes are enriched in severe AIS cases
To explore the role of rare variants in the susceptibility to severe AIS, we performed a
gene-based rare variant burden analysis on WES data from 1,221 severe AIS cases and 1,397 inhouse controls. Our AIS cohort was ascertained due to an extreme severe scoliosis phenotype, with
the majority of cases having had spinal fusion surgery. This aggressive treatment occurs in only 1
in 10,000 individuals (Martin et al, 2014). To our knowledge, no replication cohort of severe
scoliosis cases exists. Therefore, to maximize the likelihood of detecting true enrichment of rare
variants within a single gene, (and minimize the risk of spurious association due to small number
of individuals and lack of a traditional replication cohort), we repeated the burden analysis by
comparing our AIS case data to a second, much larger control cohort of 125,748 individuals from
gnomAD global population using previously described methods (Guo et al, 2018).
By limiting our analysis to ultra-rare nonsynonymous missense variants, defined as a minor
allele count (MAC) ≤ 3 in case and control cohorts, we sought to identify extremely rare variants
contributing to the familial clustering often seen in AIS. Analysis was restricted to genes with a
greater burden of ultra-rare variants in cases compared to controls (OR >1). There were 119 genes
with burden analyses yielding p-values < 0.05 compared to both in-house controls and gnomAD
global population controls. No single gene surpassed exome-wide significance in this analysis.
Two of the top 10 genes with the most significant enrichment of ultra-rare nonsynonymous
variants in AIS cases, FNDC1 and FBN1, belong to the core matrisome gene set (Naba et al, 2016;
Naba et al, 2012; Naba et al, 2017) (Table 4.1).
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4.4.3 Association of AIS with FNDC1 rare variants
Within the group of 262 core matrisome genes, the strongest enrichment of rare variants in
AIS cases was seen in FNDC1 (fibronectin type III domain containing 1)(Table 4.1 and Figure
4.1), which harbored ultra-rare missense variants in 3.9% of severe AIS cases (48/1221) compared
to 1.8% of in-house controls (25/1397)(p=6.63 x 10-4, OR = 2.2). Enrichment of rare variants in
FNDC1 in AIS cases was also strongly confirmed in comparison to 125,748 gnomAD global
population controls (p=5.76 x 10-4, OR = 2.3). Clinical features including age, Cobb angle, height,
and Beighton hypermobility scores did not differ between AIS patients harboring FNDC1 rare
variants and those without (Supplemental Table 4.1,4.2).
A similar association was observed between rare FNDC1 nonsynoymous missense variants
and scoliosis in patients of European ancestry (n = 84,717) in the Geisinger MyCode cohort
(p=0.027, OR=1.5), a healthcare population with paired exome and clinical data (Table 4.2).
4.4.4 fndc1 stop-gain effects in zebrafish
To understand the mechanism by which FNDC1 contributes to AIS severity, we
investigated the functional effects of a nonsense allele in the zebrafish line, fndc1sa23734 (Figure
4.4). Morphological analysis of fndc1+/+, fndc1+/ sa23734, and fndc1sa23734/sa23734 zebrafish did not
reveal increased rates of scoliosis, spinal fusions, or other gross abnormalities. To further examine
the fish, we used quantitative analysis of micro-computed tomography (microCT). This is a
technique wherein X-ray projection images are taken at multiple angles from a fixed sample,
generating a stack of visual slices. From this, a 3-dimensional image can be recreated and various
measurements can be extracted (Cheng et al, 2011). We isolated three individual vertebral centra
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from each fish for analysis (vertebrae 5th, 6th, and 7th from the tail). This allowed us to individually
the parameters of specific bones (Figure 4.2).
First, we examined cross-sectional area of the vertebrae. While cross-sectional area of bone
was only slightly different between fndc1sa23734/sa23734 and wild type siblings, total cross-sectional
area was significantly different between fish carrying the fndc1sa23734 allele and wild type siblings
(Figure 4.3). This suggests that the hollow within the centra is larger in mutant fish.
Next, we examined tissue mineral density in the bone of the vertebrae. This measures the
density of HA (calcium-hydroxyapatite) per unit volume in the bone tissue (Mei et al, 2017). HA
is the form in which calcium crystalizes in the bones (O'Keefe et al, 2016). This data revealed that
zebrafish carrying fndc1sa23734 alleles had significantly increased bone mineral density (Figure 4.3).
Given that vertebrae are hollow, we also measured the average thickness of this bone.
While this measurement was not significantly different between genotypes, the standard deviation
of bone thickness was significantly different in fndc1sa23734 homozygotes (Figure 4.3). While the
average thickness of the vertebrae was the same in each genotype, it appears that fndc1sa23734
homozygotes have more variability of bone thickness in each vertebra than siblings.
We also used this data to calculate polar moment of inertia (pMOI) of each vertebrae. This
is a calculation of bone strength via spatial parameters of the bone (Wergedal et al, 2003). The
calculation determines the distribution of bone around the center of the cross section. This
calculation is inversely related to shear stress in the bone induced by a given level of torque
(Schoenau et al, 2001). This is a predictor of torsional stiffness based on shape (Martin & Burr,
1984). We found significantly higher pMOI in fish carrying the fndc1sa23734 allele (Figure 4.3).

84

4.4.5 Investigating fndc1sa23734 expression
Currently, there are no Fndc1 antibodies to our knowledge available to test for protein
translation in zebrafish, via Western blot or IHC. Therefore, we opted to test for fndc1 transcript
in the fndc1sa23734 line. We performed reverse-transcriptase PCR (RT-PCR) on RNA extracted
from fndc1sa23734/sa23734 fish and wild type sibling controls. Unfortunately, we were able to amplify
RNA (data not shown), indicating that the stop-gain mutation may not have induced complete
nonsense-mediated decay, and there may be truncated protein produced in cells.
4.4.6 Generation of true fndc1 knockout
FNDC1 has several alternative splice variants in humans, which may provide one
explanation for this observation. Therefore, to further study the role of fndc1 in skeletal
development, we designed a CRISPR guide to induce a frameshift mutation near the N-terminus
of the gene, as well as in reported splice variants (Figure 4.4). This would allow us to corroborate
our mutant phenotype with a true knockout zebrafish fndc1 line.
Preliminary high-throughput sequencing via MiSeq of F0 gRNA target site 1 crispants has
returned a high degree of deletion induction, which is encouraging in estimation of gRNA
efficiency (Table 4.3). We observed an average deletion efficiency of 0.523126 in whole embryos,
where an efficiency of 1 indicates total DNA cutting at the gRNA site.
This line is currently being generated, and its characterization will be performed by other
members of the Gurnett Lab in the future.
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Figure 4.1. FNDC1 ultra-rare nonsynoymous missense variants are enriched in
AIS cases. Variants observed in AIS cases (purple) and in-house controls (blue).
Green, N-terminal signal peptide. Blue, fibronectin type 3 domain.
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Figure 4.2 Representative microCT images of isolated adult zebrafish
vertebrae. (A) Lateral (top left) and rostral (bottom left) microCT images of zebrafish
vertebra. Images of corresponding cross-sections along length of vertebra shown to
the right. (B) Images representing source of measurements taken from microCT.

87

88

Figure 4.3 The fndc1 nonsense allele (fndc1sa23734) is associated with
differences in vertebral centra. MicroCT scans of zebrafish (N=5 for each
genotype) were analyzed for various parameters. 3 vertebrae from each fish were
examined individually. P-values comparing each genotype are displayed. (A) Mutant
fish may have slightly larger area of bone in cross-section. (B) Mutant fish have
significantly increased total vertebral cross-sectional area compared to wild-type
siblings. (C) Mutant fish have significantly higher tissue mineral density in vertebrae,
scaling with fndc1sa23734 allele dosage. (D) There is no significant difference in
average cross-sectional bone thickness between siblings. (E) Mutant heterozygotes
and homozygotes have higher polar moment of inertia compared to wild type. (F)
Mutant homozygotes have a higher bone thickness standard deviation compared to
siblings, indicating more variability in bone thickness. P-values were calculated
using Wilcoxon rank-sum test, two-sided. Points represent individual vertebrae.
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Figure 4.4 Schematic of fndc1 zebrafish gene and splice variant. fndc1sa23734
nonsense allele indicated in red. gRNA target sites indicated in orange.
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Table 4.1 Ultra-rare nonsynoymous missense variants in core matrisome
genes are enriched in severe AIS. Top 15 core matrisome genes with variant
counts and percentages (in parenthesis) for severe AIS cases and in-house controls
having p-values ≤ 0.05. Combined all 262 tested core matrisome genes, combined
top 15 core matrisome genes, and combined core matrisome for Collagens, ECM
Glycoproteins and Proteoglycans respectively. P-values were calculated using
Fisher’s exact, one-sided.
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5.76E-04
7.30E-05
6.99E-03
0.67
0.17
0.85
9.17E-03
0.31
0.54

2.3
2.4
2.3
0.9
1.5
0.5
3.5
1.2
1.1

945 (0.8%)
1123 (0.9%)
597 (0.5%)
700 (0.6%)
545 (0.4%)
192 (0.2%)
178 (0.1%)
936 (0.7%)
186 (0.1%)

21 (1.7%)
26 (2.1%)
13 (1.1%)
6 (0.5%)
8 (0.7%)
1 (0.1%)
6 (0.5%)
11 (0.9%)
2 (0.2%)

6.63E-04
1.97E-03
3.97E-03
4.63E-03
7.95E-03
0.02
0.03
0.03
0.03

2.2
2.1
2.5
2.2
1.9
3.0
1.6
3.2

25 (1.8%)
13 (0.9%)
18 (1.3%)
26 (1.9%)
0
5 (0.4%)
34 (2.4%)
4 (0.3%)

45 (3.7%)
28 (2.3%)
34 (2.8%)
42 (3.4%)
5 (0.4%)
13 (1.1%)
46 (3.8%)
11 (0.9%)

Collagens
ECM Glycoproteins
ECM Glycoproteins
Proteoglycans
Proteoglycans
ECM Glycoproteins
ECM Glycoproteins

PXDNL
PAPLN
OMD
HAPLN1
AGRN
EMID1

P-value

25 (1.8%)

OR

gnomAD controls
(N=125,748)

Severe AIS
cases
(N=1,221)

P-value

0.02
1.59E-03
0.82
0.19
0.53
2.5E-07
1.4E-08
3.8E-03
6.4E-06
0.33

4.2
2.4
0.8
1.4
1.1
1.1
1.7
1.2
1.2
1.0

98 (0.1%)
688 (0.5%)
953 (0.8%)
832 (0.7%)
182 (0.1%)
125874 (0.4%)
8155 (0.5%)
28052 (0.5%)
86098 (0.4%)
11724 (0.3%)

4 (0.3%)
16 (1.3%)
7 (0.6%)
11 (0.9%)
2 (0.2%)
1403 (0.5%)
134 (0.8%)
318 (0.6%)
966 (0.4%)
119 (0.3%)

0.03
0.04
0.04
0.05
0.05
0.05
7.19E-05
2.60E-17
0.40
2.3E-04
5.3E-03

4.6
1.6
1.8
1.8
2.9
1.4
1.1
1.9
1.0
1.1
1.2

2 (0.1%)
27 (1.9%)
18 (1.3%)
17 (1.2%)
4 (0.3%)
51 (3.7%)
5088 (1.4%)
269 (1.3%)
1183 (2.1%)
3493 (1.3%)
412 (0.9%)

8 (0.7%)
38 (3.1%)
28 (2.3%)
26 (2.1%)
10 (0.8%)
61 (5%)
4799 (1.5%)
443 (2.5%)
1046 (2.1%)
3323 (1.5%)
430 (1.1%)

ECM Glycoproteins
ECM Glycoproteins
Collagens
Collagens
ECM Glycoproteins

TNR
LAMB4
COL14A1
COL26A1
OTOG
Core matrisome genes
(N=262)
Top core matrisome genes
(N=15)
Core - Collagens genes
(N=42)
Core - ECM Glycoproteins genes
(N=188)
Core - Proteoglycans genes
(N=32)

COL2A1

ECM Glycoproteins

ECM Glycoproteins

FBN1

MFAP5

48 (3.9%)

ECM Glycoproteins

FNDC1

In-house
controls
(N=1,397)

OR

Severe AIS
cases
(N=1,221)

Core Matrisome
Type

Gene

Table 4.2 Ultra-rare FNDC1 nonsynoymous missense variants are associated
with scoliosis in the Geisinger MyCode cohort.

Diagnosis Codes in EHR

Any Scoliosis Diagnosis

36 (7.48%)

FNDC1
Negative
(N=84,248)
4509 (5.35%)

Multiple Scoliosis Diagnoses

18 (3.74%)

1555 (1.85%)

2.07

0.0043

9 (1.87%)

466 (0.55%)

3.46

0.0017

Scoliosis Diagnosis Before 18 y/o

FNDC1 Positive
(N=481)
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OR

P-value

1.43

0.0290

Table 4.3 Deletion in duction efficiency in fndc1 target site 1 crispant embryos.
Whole F0 embryos were lysed and sequenced via Miseq. From the total amplified
fragment read list, we analyzed each sequence for the gRNA target sequence, and a
sequence in the gene upstream of this sequence. The ratio of reads not containing
the gRNA target sequence : upstream sequence was used to estimate deletion
efficiency in each embryo. The average efficiency across all embryos was 0.523126.
Total
Read
Counts
121430

gRNA
Target
Sequence
counts
28531

149253

Upstream Ratio
counts
deletion

Total
gRNA
upstream
ratio
Read
Target
counts
deletion
Counts Sequence
counts
39132
16573
35855 0.537777

105763

0.730236

57379

125991

0.544579

52689

21538

45458

142683

65454

135707

0.517681

36620

15601

33884 0.539576

6933

2654

6572

0.596166

76082

24689

54134 0.543928

29

16

27

0.407407

54384

18186

48226 0.622901

96

28

88

0.681818

49805

18642

48520 0.615787

159

39

121

0.677686

58958

28124

54468

230704

79688

177077

0.549981

42133

23800

38878 0.387829

220365

79353

144424

0.450555

20695

7893

19756 0.600476

630

384

605

0.365289

30708

16594

26805 0.380936

8624

4561

8390

0.456377

29032

12119

26028 0.534386

6

0

4

1

33611

19045

30993 0.385506

334919

122576

294568

0.583879

34072

19565

32181 0.392033

215043

59756

202030

0.704222

190366

122093

175615 0.304769

296929

125182

281893

0.555924

190215

87958

168334 0.477479

94

0.5262

0.48366

Total
Read
Counts

gRNA
Target
Sequence
counts
77719
36573

upstream
counts

ratio
deletion

73237

0.500621

Total
gRNA
upstream
Read
Target
counts
Counts Sequence
counts
180016
84825
157858

ratio
deletion

0.46265

135836

48487

132178

0.633169

67670

40924

66106 0.380934

123123

73367

118059

0.378556

91109

56378

81245 0.306074

114418

55413

110070

0.496566

53378

28682

49065 0.415429

159603

37706

146803

0.743152

10688

3682

9889 0.627667

40577

15170

36919

0.5891

30614

8388

24246 0.654046

14705

7612

12093

0.370545

43675

16558

38269 0.567326

32924

15739

30874

0.490218

39132

16573

35855 0.537777

41667

15911

26857

0.407566

52689

21538

45458

36995

21559

34757

0.379722

36620

15601

33884 0.539576

63492

27830

62071

0.551642

76082

24689

54134 0.543928

49805

18642

48520

0.615787

54384

18186

48226 0.622901
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0.5262

4.5 Discussion
By leveraging a large, multicenter collaborative cohort comprising individuals with severe
AIS, most of whom have had spinal fusion surgery, we identified a key role for extracellular matrix
proteins (the “matrisome”) in its etiology. The core matrisome is a curated set of 274 genes
encoding extracellular matrix proteins, including glycoproteins (fibronectins, laminins, tenascins,
thrombospondins, fibrillins, fibulins), collagens, and proteoglycans (Guo et al, 2018; Naba et al,
2016; Naba et al, 2012). The matrisome itself consists of more than 1000 genes including the core
matrisome genes, as well as extracellular matrix associated proteins, secreted factors, and
extracellular matrix regulators (Naba et al, 2012). Many core matrisome genes are responsible for
connective tissue disorders that cause scoliosis. In prior smaller studies, we and others have shown
that rare variants in some of these genes (i.e. FBN1) are risk factors for generalized AIS (Buchan
et al, 2014; Haller et al, 2016; Wise et al, 2020). In the current study, we present strong genetic
evidence linking these genes to severe AIS, specifically fibronectin type III domain containing 1
(FNDC1).
FNDC1 is a compelling candidate gene for AIS- a nonsynonymous variant (rs62432291)
in this gene is strongly associated with joint hypermobility as self-reported by 23andme
participants (Pickrell et al, 2016). Children, adolescents, and females have a higher prevalence of
joint hypermobility, which are risk factors for AIS (Hakim et al, 2004). Many connective tissue
disorders associated with joint hypermobility also have a high incidence of scoliosis comorbidity
(Cheng et al, 2015). Generalized joint hypermobility is also a risk factor for AIS (Czaprowski,
2014; Czaprowski et al, 2011). Other than its association with joint hypermobility and otitis media,
relatively little is known about FNDC1 except that it is ubiquitously expressed, with higher
expression in skeletal muscle, bone, and spinal cord (Nagase et al, 2001; Pickrell et al, 2016; Van
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Ingen et al, 2016). The FNDC gene family contains 9 members, with some evidence that FNDC1
and FNDC5 regulate bone mineral density (Colaianni et al, 2017; Singhal et al, 2014; Xiao et al,
2019). Specifically, FNDC1 expression was elevated in an osteoporotic rat model, whereas rutin
treatment suppressed FNDC1 expression and increased bone mineral density (Xiao et al, 2019).
MicroCT analysis of fndc1 nonsense zebrafish confirm its role in regulating bone mineral
density (Figure 4.3). Several human conditions are associated with increased bone mineral density,
including osteopetroses and sclerosing bone dysplasias which may also present with severe
scoliosis (Gregson & Duncan, 2020; Laine et al, 2011). Bone mineral density is a function of
calcium and phosphorus deposition in the form of HA (Almeida Paz & Bruno, 2006). Being an
ECM protein, it is possible that fndc1 plays a role in HA deposition.
The shape of vertebrae also appears to be affected in our fndc1 nonsense mutants. A higher
cross-sectional area in vertebrae, but not in bone area, indicates that the hollow centra is larger in
our mutants. We also observed a higher standard deviation ofbone thickness in homozygotes,
indicating greater variability in the thickness of the walls of the vertebrae. Furthermore, we
observed a higher pMOI in fndc1sa23734 carriers- because this metric is a function of distribution of
tissue, this also supports that the vertebral shape is altered in our mutants (Jepsen et al, 2003).
While the mechanism is not yet clear, the effect of fndc1 mutation on vertebral composition
and morphology supports its role in vertebral development. While we did not observe a gross
phenotype in our zebrafish, it is possible that mutation of this gene acts as a risk factor in AIS
onset as opposed to a direct cause. Indeed, this is consistent with our exome data analysis- we
show that FNDC1 variants function as risk factors contributing to a ~2-fold increased risk of severe
AIS. As expected for risk factors for complex disease, FNDC1 variants show incomplete
penetrance and imperfect familial segregation (Supplemental Figure 4.1).
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Further, missense mutations such as those in our exome analysis often have wildly different
effects on phenotype and protein function than loss-of-function mutations (Whittle et al, 2020). In
the future, the fndc1 loss-of-function mutants may be a useful tool in identifying mutations that,
when combined with other mutations, result in a deleterious effect on gross morphology. In
addition, functional testing of reported AIS-associated FNDC1 SNPs may be useful in directly
addressing the mechanisms by which FNDC1 mutations result in AIS, and which variants are
pathogenic.
Despite inclusion of more than 1000 AIS patients in this multicenter study, rare variant
burden analyses remain challenging due to their low frequency and the resultant low power to
detect single gene associations. To mitigate the possibility of identifying spurious associations, we
confirmed our rare variant burden analysis results by also comparing our case data to the gnomAD
dataset, which provides a much larger control cohort (Karczewski et al, 2020). Our burden analysis
was strengthened by our replication of the association of FNDC1 rare variants with scoliosis in the
Geisinger MyCode cohort. Once confident in the association of FNDC1 and severe AIS, our
zebrafish model confirmed its role in vertebrae morphology via various parameters. Overall, our
results demonstrate a compelling association of AIS with alteration of FNDC1, which may
contribute to severe scoliosis by regulating joint hypermobility, vertebral morphology, and bone
mineral density.
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4.6 Supplemental materials
A

B

Supplemental Figure 4.1 FNDC1 ultra-rare nonsynoymous missense variants
partially segregate with incomplete penetrance in AIS in families. (A)
Segregation of FNDC1 ultra-rare missense variants in families with probands who
were included in the gene burden analysis. (B) Segregation of FNDC1 variants in
additional AIS families that were not included in the gene burden analysis. Black is
AIS.
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Patients (%)

Beighton score ≥ 4 pts

1.97 (2) ± 2.03

Beighton Mean (Median) ± S.D.

164 (13%)

538 (44%)

53th (55th) ± 29.6

Height (thpercentile) Mean (Median) ± S.D.

Patients (%)

55.5° (55°) ± 13.0

Cobb Angle Mean (Median) ± S.D.

Beighton score ≤ 3 pts

23.8 (16) ± 16.5

(N=1,221)

AIS

Age Mean (Median) ± S.D.

Characteristics

149 (15%)

449 (44%)

2.11 (2) ± 2.07

53th (55th) ± 29.5

55.3° (54°) ± 13.0

24.2 (16) ± 16.9

(N=1,022)

Female AIS

15 (7%)

89 (45%)

1.19 (0) ± 1.53

51th (48th) ± 30.6

56.3° (55°) ± 13.2

22.1 (17) ± 14.3

(N=199)

Male AIS

Supplemental Table 4.1: Demographics of severe AIS cohort.
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1.77 (1) ± 2.16

Mean (Median) ± S.D.
Mean (Median) ± S.D.

Height (thpercentile)

Beighton
Patients (%)
Patients (%)

Beighton score ≤ 3 pts

Beighton score ≥ 4 pts
7 (15%)

24 (50%)

50th (50th) ± 26.8

Mean (Median) ± S.D.

Cobb Angle

7 (18%)

19 (50%)

2.04 (2) ± 2.24

53th (54th) ± 26.5

56.4° (50°) ± 15.5 55.9° (50°) ± 15.2

Mean (Median) ± S.D.

Age

Female AIS
(N=38)
25.5 (16) ± 18.3

AIS
(N=48)
24.1 (16) ± 17.2

Characteristics

0

5 (50%)

0.4 (0) ± 0.09

35th (24th) ± 26.1

58.1° (63°) ± 17.2

Male AIS
(N=10)
16.2 (16) ± 3.0
Supplemental Table 2: Demographics of severe AIS patients with FNDC1 ultra-rare

missense variants.
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4.7 Materials and Methods
4.7.1 Cohort description
Severe AIS cases were recruited from a multicenter collaborative effort, including
Washington University School of Medicine (WUSM; n=855), University of Wisconsin (UW;
n=28), University of Colorado (UC; n=58) and Texas Scottish Rite Hospital (TX; n=280)
(Supplementary Table 6)(n= number whose sequencing data passed QC). We included unrelated
individuals of European ancestry with severe spinal curvature with a Cobb angle of at least 35
degrees, juvenile or adolescent onset, and excluded cases with congenital or infantile scoliosis,
known or suspected underlying disorder or syndrome. The institutional review board at each
institution approved this study and all patients and/or parents provided informed consent. In-house
control subjects consisted of healthy individuals or patients ascertained for conditions other than
scoliosis (i.e Alzheimer’s disease, Amyotrophic Lateral Sclerosis, or male infertility).
4.7.2 Whole-exome sequencing, data processing and quality control
Exome libraries were prepared using Agilent's SureSelect Human All Exon kits V5 or IDT
xGen Exome Panel V1 capture. Samples were sequenced at the McDonnell Genome Institute on
Illumina HiSeq 2000/4000 with paired-end reads. Exome data from AIS cases is available at
dbGaP (Study Accession: phs001677). Sequencing reads (i.e. fastq files) from all severe AIS case
and in-house control samples were aligned to the human genome Reference (GRCh37) using
BWA-MEM (v0.7.15). Aligned sequencing data (i.e. BAM files) were sorted and marked for
duplication using Picard MarkDuplicates (v2.9.0). All case and in-house control BAM files were
processed following GATK's (v3) Best Practices47. Variant calling was performed using
HaplotypeCaller (GATKv3) individually, producing an intermediate vcf file (i.e. GVCF file) for
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each WES sample. All GVCF files were combined using CombineGVCFs (GATKv3) and then
variant joint calling were performed for all cases and in-house control samples using
GenotypeGVCFs (GATKv3). Multiallelic variants were decomposed into biallelic variants.
Variant Quality Score Recalibration (VQSR) was performed separately for SNPs and INDELs
using VariantRecalibrator (GATKv3). Variants were evaluated and only SNPs above the
confidence threshold of 99.7, as indicated by VQSR, were considered for further analysis. We
removed all X-chromosome variants from further analysis due to the sex imbalance in our cases
and controls. Variants within low complexity and repetitive regions were also removed.
Additional hard filters implemented for variant genotype quality control comprise of variants with
depth (DP) of at least 10 reads with genomic quality (GQ) of at least 20, and allele balance (AB)
for heterozygous calls between 0.2 and 0.8. Samples with genotype call rate < 90% or whose
genotype data indicated a sex discordant from the clinical database were excluded.
4.7.3 Variant annotation and statistical analysis
Gene and variant functional annotation was performed using VEP tool with GENCODE
(v19), gnomAD exomes (r2.1.1), and CADD scores (v1.4) database (Frankish et al, 2019;
Karczewski et al, 2020; McLaren et al, 2016; Rentzsch et al, 2019). Principal component analysis
(PCA) was calculated to verify ancestry and restrict our analysis to only individuals of European
ancestry (Supplementary Figure 1). Individual and familial relatedness was confirmed using
kinship inference analysis KING and only unrelated individuals were kept for further analysis
(Supplementary Figure 2) (Manichaikul et al, 2010). Single-variant association analysis was done
using PLINK (v1.9). We used a minor allele frequency cutoff of 0.05 (MAF ≥ 0.05) and with
genotype call rate ≥ 90% in cases and controls. We removed variants that were in deviation from
Hardy Weinberg equilibrium (p < 1 × 10−6). Fisher Exact test with Lancaster’s mid-p adjustment
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(Plink –assoc fisher-midp) was used to estimate association between single variants and severe
AIS. The established threshold of 5 × 10−8 was used to identify genome-wide significance.
Quantile-quantile and Manhattan plots were created using R.
Associations at the gene level were tested using R and Rvtests Exact CMC model which
collapse and combine variants, and then perform Fisher’s Exact test. We focused on ultra-rare
missense variants with minor allele count cutoff of 3 (MAC ≤3) and with genotype call rate of at
least 90% in cases and in-house controls. For gene-based association analysis of severe AIS cases
compared with gnomAD database as controls, using TRAPD methods (Guo et al, 2018). Pathway
enrichment analysis was performed with Metascape (Zhou et al, 2019).
4.7.4 Geisinger cohort description and data analysis
Exome sequence data for MyCode participants generated through the Geisinger-Regeneron
DiscovEHR collaboration, for which details of the sequencing methods are described in Staples et
al, were evaluated to identify individuals harboring ultra-rare FNDC1 missense variants (MAC ≤3
in gnomad exomes.r2.1.1 and MAC ≤ 3 in the DiscovEHR unrelated European subset) (Staples et
al, 2018). Genomic variants were annotated using VEP (v100) and were required to meet the
following thresholds: GQ ≥ 20, DP ≥ 10, AB ≥ 0.25 and alternate depth ≥ 3 (Van der Auwera et
al, 2013). Additionally, we excluded variants located in tandem repeats, homopolymer runs, low
complexity regions, and exon 1 (due to inconsistent coverage) (Krusche et al, 2019; Li, 2014). We
further limited our analysis to 85,164 unrelated participants (to the second degree as
computationally determined) of European ancestry computed using principal components
calculated as previously described (Staples et al, 2018). After applying the aforementioned variant
filters and removing individuals with unavailable EHR data, we identified 84,717 participants
eligible for inclusion in the data analysis: 469 harboring ultra-rare FNDC1 (transcript
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ENST00000297267.14) missense variants and 84,248 without ultra-rare variants. Scoliosis
phenotypes were determined by extracting relevant scoliosis diagnosis codes from the EHR as
specified by an orthopedic surgeon (Supplementary Table 9). Diagnosis codes only counted
towards a scoliosis phenotype if they were observed in two different EHR encounters. After
meeting this criterium, only a single EHR occurrence of any additional scoliosis diagnosis codes
was required to count towards a the category of “multiple scoliosis diagnoses.” These filters were
implemented to minimize the risk of including false positives due to ICD code use related to rule
out procedures and testing. It is common practice to implement a minimum number of occurrences
for ICD code usage when using this information to define phenotypes. Typically, individuals with
a true diagnosis of a medical condition that requires continuous follow-up will continually have
the relevant ICD codes documented in their EHR for the follow-up care visits. Individuals counted
as having scoliosis before 18 years of age include those with a relevant diagnosis code used before
the age of 18 or the use of any scoliosis code with the terms “infantile,” “juvenile,” or “adolescent”
in the diagnosis name (Supplementary Table 9). This study was approved by the Geisinger
Institutional Review Board and all participants provided informed consent.
4.7.5 Zebrafish husbandry
Zebrafish (Danio rerio) were raised and maintained using standard methods (Westerfield,
1995). Zebrafish were housed and handled using protocols approved by the Institutional Animal
Care and Use Committee (IACUC) at Washington University. fndc1sa23734 embryos were acquired
through the Zebrafish International Research Center (ZIRC).
4.7.6 Zebrafish fndc1sa23734 Genotyping
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Fish were in-crossed and genotyped for fndc1sa23734 via Sanger sequencing using the
following primers:
Forward: TAATTGGCCTTCCTGCACCTA
Reverse: GTATGCCTTCAGTTGCTTCACC
4.7.7 MicroCT Preparation
Adult fish were fixed for 7 days at room temperature under agitation in 4%
paraformaldehyde in PBS, and washed with 70% ethanol. Whole-animal micro-computed
tomography (microCT) was conducted on a Scanco µCT-50 instrument. Scanning and data
extraction were performed by the microCT core at Washington University in St Louis School of
Medicine. Samples were mounted in 19-mm sample holders packed with Kimwipes, dampened
with PBS to prevent drying.
Statistical analysis on zebrafish microCT data were performed in R, via Wilcoxon-rank
sum test, two-sided for each genotype group (n=5). Graphs were generated in R.
4.7.8 RT-PCR
Initial RNA was extracted using the Qiagen RNeasy kit. Initial RT-PCR was performed
using the extracted RNA, then previously described PCR performed on the resulting product.
4.7.9 Zebrafish CRISPR mutagenesis
CRISPR/Cas9 gRNA design and mutagenesis was performed using previously described
methods (Hoshijima et al, 2019). We used a dual gRNA approach for this CRISPR protocol
(dgRNA).
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To generate gRNA-Cas9 complexes for target site 1, 10 uL of 100 uM Alt-R ® tracrRNA
(IDT 1072534) was added to 10 uL 100 uM crRNA (IDT custom [/AltR1/rUrG rUrCrU rGrCrA
rArUrG rArCrU rCrCrU rGrCrG rGrUrU rUrUrA rGrArG rCrUrA rUrGrC rU/AltR2/ ]). This was
incubated at 95 oC for 5 minutes, then cooled to 25 oC at a rate of -0.1 oC/second. It was kept at 25
o

C for 5 minutes, then stored at -20 oC in 1 uL aliquots (50 uM). 1 uL dgRNA, 1 uL Cas9 protein

(25 uM), 0.5 uL phenol red, and 2.5 uL KCl (300 mM), were mixed and incubated at 37 oC for 5
minutes. Next, 1 uL NU7441 (400 mM) was added. This cocktail was injected into 1-cell stage
zebrafish embryos.
Larvae were collected for DNA extraction at 5 dpf for CRISPR efficiency analysis. They
were genotyped via MiSeq using the following primers:
Forward: CTAGAGAACTTCCGTCGCATTT
Reverse: AGAAACAGTTTGACCTACCCGA
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Chapter 5: Conclusions and Future Directions
5.1 Perspective
Musculoskeletal disorders can severely impact the quality of life of affected patients.
Skeletal muscle comprises about 40% of human body mass, and 50-75% of individual proteins
(Frontera & Ochala, 2015). Alteration in the function or structure of its elements can drastically
influence daily life. For example, activities as simple as walking can become painful and
cumbersome for patients with congenital disorders of the musculoskeletal system (Kimber et al,
2012).
Many genes work in tandem to regulate the structure and function of muscle, joints, and
bones. Genes in muscle, nerve tissue, and connective tissue can affect the musculoskeletal system.
In addition, genes expressed extracellularly from any of these tissues can interact and impact the
musculoskeletal system. Because these tissues are so interconnected, mutations in genes expressed
in widely divergent tissues can produce similar phenotypes. For example, mutations in both muscle
and nerve genes have been discovered as causative in Distal Arthrogryposis (DA) (Chong et al,
2020; Coste et al, 2013; Gurnett et al, 2010; McMillin et al, 2013; Toydemir et al, 2006; Whittle
et al, 2021). Even within the same gene, different mutations can have differing effects on protein
function (Del Angel et al, 2020). However, it may be difficult to predict how these divergent effects
may affect gross morphology or tissue structure without studying humans with these variants, or
functional testing of mutant protein in a model system.
Currently, musculoskeletal disorders are primarily treated conservatively with bracing or
physical therapy, and occasionally with surgical intervention (Bamshad et al, 2009). This is a “one
size fits all” approach to disorders that are caused by mutations in different genes with vastly
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differing disease mechanisms. Alternatively, studying the functional effects of individual genes or
mutations in the same gene will allow us to approach patients suffering from these disorders
individually. This precision medicine-based approach will allow us to address the underlying
issues in the proteins themselves instead of correcting secondary, downstream phenotypes.
Determining the functional effects of mutations often requires directly testing mutant
protein function. While single-molecule studies are useful for determining molecular qualities of
protein function, animal models allow us to study these functional effects on organ systems. In
particular, animal models allow us to study how mutations affect cellular and tissue structure and
function.
The objective of this thesis was to develop and test vertebrate models of two
musculoskeletal disorders- DA and Adolescent Idiopathic Scoliosis (AIS). We leveraged the
benefits of using zebrafish as vertebrate models, with the primary focusing being on the genes
smyhc1 and fndc1.
5.2 smyhc1 zebrafish mutants as models for distal arthrogryposis
In Chapter 2, we describe a smyhc1R673H missense zebrafish mutant. This mutation is a
direct analog to the most common mutation (MYH3R672H) associated with DA2A (FreemanSheldon Syndrome) (Toydemir et al, 2006; Whittle et al, 2020). DA2A is considered the most
severe form of DA, presenting with severe contractures in the hands, feet, and face. Our mutant
fish phenocopied the human disease, with kinks in notochord being caused by muscle
hypercontraction that developed into vertebral fusions and scoliosis. The phenotype severity
increased with allele dosage, with homozygous lethality and severe body curvatures. This mutation
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is inherited in an autosomal dominant manner in humans as well, with no homozygous cases of
this allele having been described.
We characterized the smyhc1R673H mutant by examining muscle structure, swim capacity,
and skeletal structure. We demonstrate that smyhc1R673H mutants displayed shortened sarcomeres
and muscle fibers, as well as diminished swim capacity in larval stages and adulthood. This
mutation affects both structure and function of the muscle, with non-autonomous effects on
skeletal structure. We hypothesized that increased tension produced by the muscle led to these
phenotypes.
To test the hypothesis that increased tension produced by the muscle led to these
phenotypes, we used pharmacological inhibition of many of the pathways required for muscle
contraction. First, neural anesthetic failed to rescue this phenotype, suggesting that this errant
muscle function was constitutive and independent of neural stimulation. Indeed, intervention with
para-aminoblebbistatin, which directly inhibits actin-myosin interaction through myosin ATPase
inhibition, prevented body curvature and kinking of the notochord. In the future, specific
pharmacologically inhibition of embryonic skeletal muscle contraction in developing human
fetuses with this mutation may prevent DA from developing or progressing.
In Chapter 3, we describe a higher throughput method of smyhc1 mutagenesis and
screening using a GFP reporter which is an ongoing collaboration between the Gurnett and
Johnson labs. While we were able to functionally examine the effects of the MYH3R672H mutation
using the zebrafish smyhc1R673H model, many more variants have been reported in this gene in
human patients. Many of these variants are of unknown significance, and without functional testing
it is difficult to determine the pathogenicity of these mutations. Because variant mutagenesis is so
time and labor intensive, a higher throughput method of variant induction is necessary. With our
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novel approach, a GFP reporter was introduced at the C-terminus of the smyhc1 gene. Removal of
a region of interest, where many of the reported variants cluster, via CRISPR puts the GFP out of
frame. Upon subsequent successful in-frame integration of a variant of interest in this region, GFP
expression is restored, allowing for efficient screening of F0 embryos. This new screening method
will be enable efficient identification of successful integration events, as it will use GFP as a visual
cue instead of multiple rounds of high-throughput sequencing. Embryos with high GFP expression
in many cells will be more likely to carry the variant in the germline, allowing for efficient
screening of germline candidates as well. In addition, F0 fish can be analyzed, as the mononucleate
cells expressing GFP will carry the integrated variant. Overall, this method will allow for more
streamlined screening for successful mutagenesis, drastically reducing the time and labor in
generating mutant zebrafish lines. A large number of reported MYH3 variants can then be
characterized in much less time.
5.3 fndc1 mutant effect on Zebrafish skeletal structure, and the link between FNDC1 and
AIS Progression
In Chapter 4, we describe the gene burden analysis that identified FNDC1 as a significant
genetic risk factor for AIS progression. FNDC1 ultra-rare variants were significantly enriched in
severe AIS patients compared to 2 control sets. To study the mechanism by which FNDC1 variants
may contribute to scoliosis pathogenesis, we characterized fndc1 nonsense zebrafish mutants to
examine the effect of this gene on skeletal morphology. Without observing a gross phenotype, we
examined the vertebrae more closely using microCT. Here, we found that fndc1 mutants had higher
tissue mineral density in the vertebral bones with a differing vertebral shape, which was
proportional to allele dosage. Alteration of tissue mineral density may be one of the mechanisms
by which FNDC1 variants contributes to AIS risk.
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Consistent with the absence of a scoliosis phenotype in fndc1 zebrafish null mutants,
FNDC1 variants did not perfectly segregate with AIS in our family pedigrees. This may suggest
that FNDC1 variants may act as risk factors for AIS, as opposed to a highly penetrant fully
dominant pathogenic variants. To further test this, generation of models with multiple mutations
may be used to determine the additive effects that result in AIS.
5.4 Conclusions
Overall, the findings presented here expand our understanding of MYH3-driven DA, and
the potential role of FNDC1 in severe AIS. These studies lay the groundwork for phenotype
characterization of pathogenic skeletal muscle gene alleles in zebrafish, as well as a method for
examining many variants of a gene in an efficient manner. Patient phenotypes are difficult to
predict. Therefore, an understanding of gene function and how mutations affect that function will
enable the development of predictive models for variant pathogenicity. Zebrafish are a useful tool
in understanding the disease mechanism of musculoskeletal disorders, as well as exploring
treatment methods that may be adapted for human patients. Our work may subsequently lead to
precision medicine for patients affected by musculoskeletal disorders.
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